COVID-19 Evidence Reviews
as of 9/22/21
menu
 
 

Today's Feature

9/22/2021
This paper discusses the challenges faced when conducting LSRs in the context of the COVID-19 pandemic, and to provide methodological guidance for others doing similar work. The authors determine that a LSR is a very suitable review type for the pandemic context.



Completed Reviews
 
= living review
= meets mimimum quality standards   |  

A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
latest update
date
report
select
9/22/21
Lashkari A, Ranjbar R | J Neurovirol
Aim: To review the case studies of COVID-19-related acute cerebrovascular diseases such as ischaemic stroke, intracerebral hemorrhage, and cerebral sinus thrombosis. 
9/22/21
Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, et al. | J Eur Acad Dermatol Venereol
Aim: To assess the prevalence of COVID-19 (diagnosed using PCR and/or serology) in patients with CLL.
RECENTLY UPDATED
9/22/21
Farrukh L, Mumtaz A, Sana MK | Rev Med Virol
Aim: To study the possibility of re-infection in patients diagnosed with Covid-19, after being discharged from the hospital. 
9/22/21
Wiedenmann M, Goutaki M, Keiser O, et al. | Swiss Med Wkly
Aim: To review the evidence on the role of children and adolescents in the SARS-CoV-2 pandemic, specifically the severity of SARS-CoV-2 presentation, risk of SARS-CoV-2 infection and risk of transmitting SARS-CoV-2.
9/21/21
Giossi R, Menichelli D, Pani A, et al. | Front Pharmacol
Aim: To evaluate the effectiveness of heparin compared to no anticoagulant treatment in reducing overall mortality.
RECENTLY UPDATED
9/21/21
Hossein Kazemi M, Kuhestani Dehaghi B, et al. | Iran J Med Sci
Aim: To explore the possible association of HScore parameters with severity in COVID-19 patients. 
RECENTLY UPDATED
9/21/21
Rapp A, Fall G, Radomsky AC, Santarossa S | Pediatr Clin North Am
Aim: To review the evidence on the impact of the COVID-19 pandemic on child maltreatment.
9/21/21
Geng J, Yu X, Bao H, et al. | Front Med
Aim: To determine the predictive value of chronic diseases for the severity and mortality of COVID-19.
9/21/21
Long Q, Li J, Hu X, et al. | Front Med
Aim: To determine the adverse effects on multiple systems and differences between severe and non-severe patients in the post-acute phase.
RECENTLY UPDATED
9/21/21
Limen RY, Sedono R, Sugiarto A, | Expert Rev Anti Infect Ther
Aim: To analyze the efficacy of JAK-inhibitors to ameliorate the outcomes of Covid-19 sufferer.
9/21/21
Porter B, Zile A, Peryer G, et al. | Soc Sci Med
Aim: To: i) synthesise evidence describing the experiences of health and social care staff providing end-of-life care during a disease outbreak or humanitarian disaster, ii) understand the impact on their mental health and wellbeing and, iii) identify means of support.
RECENTLY UPDATED
9/20/21
Diaz-Arocutipa C, Saucedo-Chinchay J, Argulian A | Clin Cardiol
Aim: To review the evidence on the prognostic utility of right ventricular dysfunction (RVD) in patients with coronavirus disease 2019 (COVID-19).
9/20/21
Zuo L, Ao G, Wang Y, et al. | J Infect
Aim: To investigate the efficacy of BAM in COVID?19.
9/20/21
Zamani R, Pouremamali R, Rezaei N | Rev Neurosci
Aim: To determine the profile and possible mechanisms behind CNS inflammatory diseases in the context of Covid-19.
9/20/21
von Bartheld CS, Hagen MM, Butowt R | ACS Chem Neurosci
Aim: To review the evidence on the role of COVID-19 and genetics on the presentation of anosmia in COVID-19 patients.
9/20/21
Alemzadeh E, Alemzadeh E, Ziaee M, et al. | Immun Inflamm Dis
Aim: To analyze the correlation between admission to ICU and hospital, disease severity, mortality, D-dimer count, lymphocyte count, and serum calcium levels.
9/17/21
Chhibber A, Kharat A, Kneale D, et al. | BMC Public Health
Aim: To measure the extent to which COVID-19 related policies reflect equity considerations by focusing on the global policy landscape around wearing masks and personal protection equipment (PPE).
RECENTLY UPDATED
INFECTION CONTROL
9/17/21
Wang Y, Greenhalgh T, Wardle J, et al. | J Eval Clin Pract
Aim: To evaluate the evidence behind claims that Chinese Herbal Medicine is an effective treatment for COVID-19.
CANDIDATE THERAPEUTICS
9/17/21
Vardoulakis S, Espinoza Oyarce DA, et al. | Sci Total Environ
Aim: To assess the risk of transmission of viral or bacterial infections through inhalation, surface contact, and faecal-oral routes in public washrooms in healthcare and non-healthcare environments.
RECENTLY UPDATED
INFECTION CONTROL
9/16/21
Ghayda RA, Lee KH, Kim JS, et al. | Int J Med Sci
Aim: To document the chest CT findings in patients with confirmed COVID-19 and their association with the clinical severity.
CLINICAL CHARACTERISTICS
9/16/21
Martins LA, Santos DVD, Marques PF, et al. | Rev Gaucha Enferm
Aim: To identify in the scientific literature the clinical overview of the pediatric population that tested positive for SARS-CoV-2 and care recommendations and recommendations among children who tested positive for SARS-CoV-2. 
CLINICAL CHARACTERISTICS
9/16/21
Piscoya A, Ng-Sueng LF, Parra Del Riego A, et al. | Arch Med Sci
Aim: To review the benefits and harms of convalescent plasma (CP) in hospitalized COVID-19 patients.
CANDIDATE THERAPEUTICS
9/16/21
Siddiquea BN, Shetty A, Bhattacharya O, et al. | BMJ Open
Aim: To assess the knowledge, attitude and practice (KAP) of the global general population regarding COVID-19.
RECENTLY UPDATED
INFECTION CONTROL
9/16/21
Barceló MA, Saez M | Environ Sci Eur
Aim: To assess the methodological limitations in studies that evaluated the effects of environmental and socioeconomic variables on the spread of COVID-19.
RECENTLY UPDATED
INFECTION CONTROL
9/16/21
Stratil JM, Biallas RL, Burns J, et al.  | Cochrane Database Syst Rev
Aim: To assess the effects of non-pharmacological measures implemented in long-term care facilities to prevent or reduce the transmission of SARS-CoV-2 infection among residents, staff, and visitors.
INFECTION CONTROL
9/15/21
Mazzaccaro D, Giannetta M, Fancoli F, et al. | J Cardiovasc Surg
Aim: To review the prevalence, the risk factors and the outcomes of venous thrombosis (VT) in patients hospitalized for COronaVirus Disease 19 (COVID-19).
CLINICAL CHARACTERISTICS
9/15/21
Mawalla WF, Njiro BJ, Bwire GM, et al. | EJHaem
Aim: To gather current evidence on the transmission of SARS?CoV?2 via blood and its derivatives.
RECENTLY UPDATED
INFECTION CONTROL
9/15/21
Hu H, Ji Z, Feng C, et al. | Integr Med Res
Aim: To analyze the innovativeness and rigorousness of the SR protocols and make recommendations for the design and implementation of future SRs on TCM for COVID-19.
CANDIDATE THERAPEUTICS
9/15/21
Ortega-Paz L, Galli M, Capodanno D, et al. | Eur Heart J Cardiovasc Pharmacother
Aim: To review the evidence on the clinical impact of different prophylactic anticoagulation regimens among hospitalized patients with COVID-19.
RECENTLY UPDATED
CANDIDATE THERAPEUTICS
9/15/21
Ming W, Zuo J, Han J, et al. | Eur Arch Otorhinolaryngol
Aim: To analyze the impact of AAD on the severity and mortality of COVID-19 patients and compare clinical outcomes between patients with and without AAD.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
9/15/21
Hesary FB, Salehiniya H | J Gastrointest Cancer
Aim: To investigate the effect of COVID-19 on the diagnosis, treatment, concerns, problems, and mental health of patients with gastric cancer.
MENTAL HEALTH
9/14/21
Weiss MJ, Hornby L, Foroutan F, et al.  | 
Aim: To create rigorously developed clinical practice recommendations that address the priorities of ODT activity during the pandemic. 
INFECTION CONTROL
9/14/21
Marasco G, Maida M, Morreale GC, et al. | Can J Gastroenterol Hepatol
Aim: To estimate the rate of gastrointestinal bleeding in COVID-19 patients and its association with mortality.
CLINICAL CHARACTERISTICS
9/14/21
Liu L, Ni SY, Yan W, et al. | EClinicalMedicine
Aim: To assess the overall and type-specific risk of mental and neurological disorders for COVID-19 infection and clinical outcomes. 
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
9/14/21
Aragoneses J, Suárez A, Algar J, et al. | Front Med
Aim: To investigate the types of oral manifestations of COVID-19 and their prevalence.
CLINICAL CHARACTERISTICS
9/13/21
Razzack AA, Hassan SA, Pasya SKR, et al. | Infect Chemother
Aim: To review the evidence on the effectiveness of remdesivir in critically ill coronavirus disease 2019 (COVID-19) patients.
CANDIDATE THERAPEUTICS
9/13/21
Becchetti C, Gschwend SG, Dufour JF, et al. | J Clin Med
Aim: To analyze and summarize the published literature concerning LT recipients with COVID-19.
CLINICAL CHARACTERISTICS
9/13/21
Jurecka A, Skuci?ska P, G?dek A | Int J Environ Res Public Health
Aim: To review current scientific reports assessing the impact of the pandemic on the physical activity, mental state, and quality of life of professional athletes.
MENTAL HEALTH
9/13/21
Prakash J, Bhattacharya PK, Yadav AK, et al. | J Crit Care
Aim: To determine the predictive accuracy of the ROX index for predicting HFNC failure in COVID-19 patients with AHRF.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
9/13/21
Sadjadi M, Mörschel KS, Petticrew M | Eur J Public Health
Aim: To identify factors influencing the acceptability and implementation of social distancing measures.
INFECTION CONTROL
9/13/21
de Freitas RF, Torres SC, Martín-Sánchez FJ, et al. | Auton Neurosci
Aim: To systematically review the recent published literature that describes syncope or presyncope as a symptom of COVID-19, having it been observed in the days before or after the diagnosis.
CLINICAL CHARACTERISTICS
9/13/21
Mahroum N, Watad A, Bridgewood C, et al. | Int J Environ Res Public Health
Aim: To investigate whether tocilizumab therapy directed against severe COVID-19 improved survival. 
RECENTLY UPDATED
CANDIDATE THERAPEUTICS
9/13/21
Channa A, Popescu N, Skibinska J, et al. | Sensors
Aim: To review the evidence on ehealth wearables for COVID-19.
DIAGNOSTICS
9/10/21
Saniasiaya J, Kulasegarah J, Narayanan P | J Laryngol Otol
Aim: To elucidate olfactory dysfunction amongst children and adolescents with coronavirus disease 2019.
CLINICAL CHARACTERISTICS
9/10/21
Heinrich J, Zhao T, Quartucci C, et al. | Gesundheitswesen
Aim: To identify epidemiological studies on the risk of infection with SARS-CoV-2 during travel by train and bus.
INFECTION CONTROL
9/9/21
Cascini F, Pantovic A, Al-Ajlouni Y, et al. | EClinicalMedicine
Aim: To review the evidence regarding attitudes and hesitancy to receiving COVID-19 vaccination among the general population in a variety of geographical contexts.
INFECTION CONTROL
9/9/21
Zinellu A, Paliogiannis P, Fois AG, et al. | Front Public Health
Aim: To capture and interpret the available evidence regarding the relationship between COVID-19 and lipid profile.
UPDATED
CLINICAL CHARACTERISTICS
9/9/21
Li H, Yan B, Gao R, et al. | Int Immunopharmacol
Aim: To assess the effects of corticosteroid therapy for patients with severe coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
9/9/21
Billings J, Ching BCF, Gkofa V, et al. | BMC Health Serv Res
Aim: To review the evidence describing healthcare workers’ experiences of working on the frontline and their views about psychosocial support, during COVID-19 or previous pandemics and epidemics, such as Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) or Ebola.
MENTAL HEALTH
9/9/21
Eberle C, Stichling S | Diabetol Metab Syndr
Aim: To examine the impact of the COVID-19 lockdown on glycemic control in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D).
INFECTION CONTROL
9/9/21
Li Y, Yang X, Yan P, et al. | Front Med
Aim: To explore the impact of metformin use on COVID-19 mortality and other patient-important outcomes across various populations and studies.
UPDATED
CANDIDATE THERAPEUTICS
9/9/21
Corica B, Marra AM, Basili S, et al. | Sci Rep
Aim: To evaluate the prevalence of RVD and associated outcomes in patients with COVID-19
UPDATED
CLINICAL CHARACTERISTICS
9/9/21
Campbell C, Andersson MI, Ansari MA, et al. | Front Med
Aim: To collate data for HBV and TB reactivation, and for complications of active HCV infection.
CANDIDATE THERAPEUTICS
9/9/21
Chaudhry MW, Zubair SM, Zubairi ABS, et al. | Adv Respir Med
Aim: To review the evidence on the effectiveness of ivermectin in hospitalized COVID-19 patients.
CANDIDATE THERAPEUTICS
9/9/21
Ciapponi A, Bardach A, Mazzoni A, et al. | Vaccine
Aim: To evaluate the effects of COVID-19 vaccines that the COVAX-MIWG selected in August 2020, or their components used in other vaccines, on pregnancy safety outcomes.
UPDATED
INFECTION CONTROL
9/9/21
Goudarzi S, Esmaeeli S, Valencia JD, et al. | Neurologist
Aim: To recapitulate the available treatments for COVID-19–related GBS and to provide a summary of clinical management strategies for this complication. 
CANDIDATE THERAPEUTICS
9/8/21
Subramaniam A, Lim ZJ, Ponnapa Reddy M, et al. | Intern Med J
Aim: To investigate the incidence, characteristics, and outcomes of patients who were readmitted to hospital emergency departments or required re-hospitalization following an index hospitalization with a diagnosis of COVID-19.
CLINICAL CHARACTERISTICS
9/8/21
Nayeri ND, Nadali J, Divani A, et al. | J Res Med Sci
Aim: To systematically review of symptoms, laboratory and radiologic findings, treatment, and outcomes of patients with COVID-19.
CLINICAL CHARACTERISTICS
9/8/21
Martins-Filho PR, Ferreira LC, Heimfarth L, et al. | Lancet Reg Health Am
Aim: To synthesize the best evidence on the efficacy and safety of HCQ as pre-and post-exposure prophylaxis and treatment of non-hospitalized and hospitalized patients with COVID-19.
CANDIDATE THERAPEUTICS
9/8/21
Shams Vahdati S, Ala A, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To systematically review the previous systematic reviews which addressed the neurological manifestations of the COVID-19 infection.
CLINICAL CHARACTERISTICS
9/8/21
Keng BMH, Gan WH, Tam YC, et al. | JAAD Int
Aim: To determine common PPE-related dermatoses, affected body sites, and implicated occupational contactants.
UPDATED
INFECTION CONTROL
9/8/21
Wang J, Chen X, Guo Z, et al. | Comput Struct Biotechnol J
Aim: To compare the superspreading potential of SARS, MERS, and COVID-19.
INFECTION CONTROL
9/8/21
Tan X, Guo J, Chen Z, et al. | Therap Adv Gastroenterol
Aim: To report on clinical outcomes of COVID-19 patients who underwent GI endoscopy.
UPDATED
CLINICAL CHARACTERISTICS
9/8/21
Veronese N, Petrovic M, Benetos A, et al. | Ageing Res Rev
Aim: To investigate whether published and ongoing phase II-III randomized clinical trials evaluating the efficacy of COVID-19 vaccines included a representative sample of older adults.
INFECTION CONTROL
9/8/21
Malekifar P, Pakzad R, Shahbahrami R, et al. | Biomed Res Int
Aim: To identify the viral coinfection prevalence among infected people with SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
9/7/21
Sari Motlagh R, Abufaraj M, Karakiewicz PI, et al.  | World J Urol
Aim: To assess the risk of SARS-CoV-2 infection and the severity of disease in PCa patients treated with ADT. 
UPDATED
CLINICAL CHARACTERISTICS
9/7/21
Minh LHN, Abozaid AA, Ha NX, et al. | Rev Med Virol
Aim: To estimate the frequency of clinical symptoms by comparing different clinical presentations based on the severity and living status of the cases.
CLINICAL CHARACTERISTICS
9/7/21
Kamarullah W, Sabrina AP, Rocky MA, et al. | Indian Heart J
Aim: To evaluate the effect of the COVID-19 pandemic on the delivery of care systems and clinical outcomes in STEMI patients.
UPDATED
INFECTION CONTROL
9/7/21
Williams SP, Leong SC | Clin Otolaryngol
Aim: To examine articles which consider either the quantification of risk or strategies to mitigate risk specifically in the setting of rhinological surgery.
INFECTION CONTROL
9/7/21
Kim JY, Han K, Suh YJ | J Cardiovasc Magn Reson
Aim: To investigate the prevalence of abnormal CMR findings in recovered COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
9/7/21
Kreuzberger N, Hirsch C, Chai KL, et al.  | Cochrane Database Syst Rev
Aim: To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs for treating patients with COVID-19, compared to an active comparator, placebo, or no intervention.
CANDIDATE THERAPEUTICS
9/7/21
Rosca EC, Heneghan C, Spencer EA, et al. | J Travel Med
Aim: To review the evidence on SARS-CoV-2 transmission aboard aircraft, report policy implications, and highlight research gaps requiring urgent attention.
INFECTION CONTROL
9/6/21
Ferner RE, Aronson JK | Oxford COVID-19 Evidence Service
9/3/21
Mutneja HR, Bhurwal A, Arora S, et al. | Scand J Gastroenterol
Aim: To evaluate whether COVID-19 affects the severity and outcomes associated with acute pancreatitis.
CLINICAL CHARACTERISTICS
9/3/21
Wang C, Wen W, Zhang H, et al. | J Am Coll Health
Aim: To study the prevalence of anxiety, depression, and stress in college students during the COVID-19 pandemic.
MENTAL HEALTH
9/3/21
 | NSW Health COVID-19 Critical Intelligence Unit
9/3/21
Bryant A, Lawrie TA, Dowswell T, et al. | Am J Ther
Aim: To assess the efficacy of ivermectin treatment among people with covid-19 infection and as a prophylaxis among people at higher risk of COVID-19 infection.
UPDATED
CANDIDATE THERAPEUTICS
9/3/21
Hesaraki M, Akbarizadeh M, Ahmadidarrehsima S, et al. | Rev Environ Health
Aim: To evaluate the knowledge, attitude, practice, and clinical recommendations of health care workers (HCWs) towards COVID-19.
INFECTION CONTROL
9/1/21
Voitsidis P, Kerasidou MD, Nikopoulou AV, et al. | Psychiatry Res
Aim: To summarize the scales that have been specifically developed for this reason and are not adaptations of already existing scales. 
MENTAL HEALTH
9/1/21
Sideli L, Lo Coco G, Bonfanti RC, et al. | Eur Eat Disord Rev
Aim: To examine the pooled prevalence of symptomatic behaviours and mental health deterioration amongst individuals with eating disorders (EDs) and obesity during the COVID-19 confinement. 
MENTAL HEALTH
9/1/21
Rathnayake D, Clarke M, Jayasinghe V. | PLoS One
Aim: To synthesize global evidence on policy strategies with a unique insight to patient prioritisation methods to reduce waiting times for elective surgeries. 
INFECTION CONTROL
9/1/21
Malik P, Patel K, Pinto C, et al. | J Med Virol
Aim: To evaluate pooled prevalence of poor quality of life in post-acute COVID-19 syndrome (PCS) and conduct meta-regression to evaluate effects of persistent symptoms and ICU admission on poor quality of life.
CLINICAL CHARACTERISTICS
9/1/21
Tricco A | SPOR Evidence Alliance
Aim: To examine the control and management of COVID-19, SARS, or MERS in adults 60 years or above living in long-term care facilities.
8/31/21
Konwar M, Maurya M, Thatte UM, et al. | Curr Rev Clin Exp Pharmacol
Aim: To analyze the safety data of HCQ against placebo and active treatment in various disease conditions.
CANDIDATE THERAPEUTICS
8/31/21
Iheanacho CO, Eze UIH, Adida EA. | Bull Natl Res Cent
Aim: To assess the evidence of “real world” effectiveness of BNT162b2 and ChAdOx1 vaccines in the general populations.
INFECTION CONTROL
8/31/21
Wang Q, Zhu H, Li M, et al. | Front Pharmacol
Aim: To evaluate the efficacy and safety of QFPD in patients with COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
8/31/21
Dutta A, Sharma A, Torres-Castro R, et al. | Indian J Psychiatry
Aim: To synthesise the currently available literature on the topic to determine the prevalence of mental health problems in healthcare workers.
UPDATED
MENTAL HEALTH
8/31/21
Samji H, Wu J, Ladak A, et al.  | Child Adolesc Ment Health
Aim: To review existing evidence of the COVID-19 pandemic's global impact on the mental health of children and adolescents <19 years of age and to identify personal and contextual factors that may enhance risk or confer protection in relation to mental health outcomes.
MENTAL HEALTH
8/31/21
Wang Y, Wang Y, Huo L, et al. | J Neurol
Aim: To review the evidence on the acute and post-infectious manifestations of SARS-CoV-2-associated ADEM to guide long-term management and health service reorganization.
CLINICAL CHARACTERISTICS
8/31/21
Cuevas-Gonzalez MV, Garcia-Perez Á, Gonzalez-Aragon Pineda ÁE, et al.  | Biomed Res Int
Aim: To evaluate the role of stem cells against SARS-CoV-2 and COVID-19 in order to identify their potential as a study model and a possible therapeutic source against tissue damage caused by SARS-CoV-2.
CANDIDATE THERAPEUTICS
8/30/21
Wang M, Luo X, Wang L, et al. | Diagnostics
Aim: To comprehensively identify the diagnostic agreement between LUS and CT in the diagnosis of interstitial pneumonia caused by COVID-19. 
DIAGNOSTICS
8/30/21
Freiberg A, Schubert M, Romero Starke K, et al. | Int J Environ Res Public Health
Aim: To investigate whether COVID-19 lockdown influences modifiable cardiovascular risk factors (i.e., physical inactivity, sedentary behaviour, smoking, alcohol use, unhealthy diet, obesity, bad blood lipids, and hypertension) in the general population.
8/30/21
Kornitzer J, Johnson J, Yang M, et al. | Int J Environ Res Public Health
Aim: To assess the spectrum of COVID-19 presentation in children, with special emphasis on characteristics associated with multisystem inflammatory syndrome (MIS-C). 
CLINICAL CHARACTERISTICS
8/30/21
O'Loughlin L, Alvarez Toledo N, Budrie L, et al. | Neurol Int
Aim: To provide an updated review of the current published data on pediatric patients with COVID-19 and coexisting severe neurological manifestations.
CLINICAL CHARACTERISTICS
8/30/21
Manzano GS, McEntire CRS, Martinez-Lage M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To synthesize the clinical features of ADEM and AHLE, response to treatments, and clinical outcomes to better understand the nature of this neurologic consequence of COVID-19 infection.
CLINICAL CHARACTERISTICS
8/30/21
Abu-Rub LI, Abdelrahman HA, Johar AA, et al. | Antibiotics
Aim: To evaluate the prevalence of antibiotic prescribing in patients admitted to ICUs with SARS-CoV-2 infection.
CANDIDATE THERAPEUTICS
8/30/21
Gil Martínez V, Avedillo Salas A, Santander Ballestín S | Pharmaceuticals
Aim: To summarize evidence on the efficacy and safety of five antivirals applied to patients with COVID-19, that have proven to be effective either in vitro studies or in studies on SARS-CoV and MERS.
CANDIDATE THERAPEUTICS
8/30/21
Moothedath M, Muhamood M, Bhosale YS, et al.  | J Pharm Bioallied Sci
Aim: To summarize if any of the animal models which are being currently used are turning out to be effective host reservoir.
8/30/21
Aram K, Patil A, Goldust M, et al. | Dermatol Ther
Aim: To evaluate presentations, post-infection change in the manifestation, diagnosis, and management of flare-ups of underlying dermatologic disease in patients with COVID-19. 
CLINICAL CHARACTERISTICS
8/30/21
Khandker SS, Nik Hashim NHH, Deris ZZ, et al. | J Clin Med
Aim: To provide an update on the diagnostic accuracy in terms of estimating the specificity and sensitivity of RAT kits in patients with suspected COVID-19.
UPDATED
DIAGNOSTICS
8/30/21
Madewell ZJ, Yang Y, Longini IM Jr, et al. | JAMA Netw Open
Aim: To examine evidence for household transmission of SARS-CoV-2, disaggregated by several covariates, and to compare it with other coronaviruses.
UPDATED
INFECTION CONTROL
8/30/21
Salomoni MG, Di Valerio Z, Gabrielli E, et al. | Vaccines
Aim: To systematically review literature on vaccine acceptance, to define more precisely the extent of VH associated with the ongoing vaccination campaign against COVID-19, and thus try to identify subpopulations at increased risk for VH, deserving target strategies.
INFECTION CONTROL
8/30/21
Sanchez-Ramirez DC, Normand K, Zhaoyun Y, et al. | Biomedicines
Aim: To explore persistent effects of COVID-19 beyond 3 months follow-up on patient chest computed tomography (CT), lung function, respiratory symptoms, fatigue, functional capacity, quality of life, and the ability to return to work. 
UPDATED
CLINICAL CHARACTERISTICS
8/30/21
Chen J, Cai Y, Chen Y, et al. | Vaccines
Aim: To calculate the pooled event rate of NMAEs after COVID-19 vaccination.
UPDATED
INFECTION CONTROL
8/30/21
Treskova-Schwarzbach M, Haas L, Reda S, et al. | BMC Med
Aim: To summarise the evidence on age-adjusted associations between multiple pre-existing health conditions and clearly defined COVID-19 outcomes separating the effects between the geographical regions.
UPDATED
CLINICAL CHARACTERISTICS
8/30/21
Rathore SS, Hussain N, Manju AH, et al. | J Med Virol
Aim: To evaluate the correlation between COVID-19 disease and pleural effusion.
CLINICAL CHARACTERISTICS
8/30/21
Treglia G, Cuzzocrea M, Giovanella L, et al. | Pharmaceuticals
Aim: To calculate the prevalence of hypermetabolic lymph nodes after COVID-19 infection.
CLINICAL CHARACTERISTICS
8/30/21
Lien CH, Lee MD, Weng SL, et al. | Life
Aim: To investigate the effects of colchicine in treating patients with COVID-19.
CANDIDATE THERAPEUTICS
8/30/21
Amereh F, Negahban-Azar M, Isazadeh S, et al. | Pathogens
Aim: To provide state-of-the-knowledge on the occurrence and existing methods for sampling procedures, detection/quantification of SARS-CoV-2 in sewage samples.
INFECTION CONTROL
8/30/21
Bignucolo A, Scarabel L, Mezzalira S, et al. | Vaccines
Aim: To investigate the influence of sex on the efficacy of COVID-19 vaccines.
INFECTION CONTROL
8/30/21
Dellazizzo L, Léveillé N, Landry C, et al. | J Pers Med
Aim: To address the mental health effects of COVID-19 on people with NCD in addition to examine the impact of the pandemic on treatments/resources for NCD.
MENTAL HEALTH
8/30/21
de Labry-Lima AO, Bermudez-Tamayo C, Martinez-Olmos J, et al. | Enferm Infecc Microbiol Clin
Aim: To compile the available evidence on the use of masks in relation to respiratory infections.
UPDATED
INFECTION CONTROL
8/30/21
Munro A, Booth H, Gray NM, et al. | Int J Environ Res Public Health
Aim: To inform current and future responses to coronavirus outbreaks by identifying and critically appraising the empirical evidence relating to the impact of novel coronavirus outbreaks of the 21st Century on problem drug users, with a particular focus on COVID-19
UPDATED
INFECTION CONTROL
8/30/21
Krzych ?J, Putowski Z, Czok M, et al. | Viruses
Aim: To investigate a possible role of TPE in severe COVID-19. 
CANDIDATE THERAPEUTICS
8/27/21
 | NSW Health COVID-19 Critical Intelligence Unit
8/27/21
Ousseiran ZH, Fares Y, Chamoun WT | Int J Neurosci
Aim: To study and summarize the different neurological manifestations of this virus.
CLINICAL CHARACTERISTICS
8/27/21
 | NSW Health COVID-19 Critical Intelligence Unit
8/27/21
 | Pan American Health Organization
Aim: To review the evidence on the therapeutic options for COVID-19.
UPDATED
8/27/21
Sarkar S, Kannan S, Khanna P, et al  | J Med Virol
Aim: To explore the utility of PLR as a prognostic predictor of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/27/21
 | NSW Health COVID-19 Critical Intelligence Unit
8/26/21
Caroselli C, Blaivas M, Falzetti S | Ultrasound Med Biol
Aim: To evaluate COVID-19 imaging options in pediatric patients
DIAGNOSTICS
8/26/21
Romoli M, Eusebi P, Forlivesi S, et al. | Int J Stroke
Aim: To review and meta-analyze variations in stroke admissions, rate and timing of reperfusion treatments during the 1st-wave COVID pandemic versus the pre-pandemic timeframe depending on stroke network model adopted.
INFECTION CONTROL
8/26/21
Qian W, Ye Y, Zuo L, et al. | Immunotherapy
Aim: To quantify the effects of immune checkpoint inhibitors (ICIs) on the prognosis of COVID-19.
CLINICAL CHARACTERISTICS
8/26/21
Saniasiaya J, Prepageran N | J Laryngol Otol
Aim: To outline the impact on quality of life in coronavirus disease 2019 patients with olfactory dysfunction.
CLINICAL CHARACTERISTICS
8/26/21
Spoorthy MS, Pratapa SK, Mahant S | Asian J Psychiatr
Aim: To review the literature about mental health problems faced by health care workers (HCW) during the COVID-19 pandemic.
MENTAL HEALTH
8/26/21
Dykgraaf SH, Matenge S, Desborough J, et al. | J Am Med Dir Assoc
Aim: To review the evidence on strategies to reduce transmission of SARS-CoV-2 in long-term care facilities.
INFECTION CONTROL
8/26/21
Banerjee S, Mahapatra AK | Rev Recent Clin Trials
Aim: To review the evidence on the use of tocilizumab for the treatment for COVID-19.
CANDIDATE THERAPEUTICS
8/26/21
Barnawi GM, Barnawi AM, Samarkandy S | Cureus
Aim: To assess the prevalence and types of dermatological manifestations associated with wearing PPE for a long time during the COVID-19 pandemic period.
INFECTION CONTROL
8/26/21
Kyiakoulis KG, Kollias A, Kyrakoulis IG, et al. | Curr Vasc Pharmacol
Aim: To identify published guidance reports by national and international societies regarding thromboprophylaxis strategies in COVID-19 patients in different settings (outpatients, hospitalized, post-discharge).
CLINICAL CHARACTERISTICS
8/23/21
Mistry DA, Wang JY, Moeser M, et al. | BMC Infect Dis
Aim: To assess the sensitivity and specificity of LFDs.
DIAGNOSTICS
8/23/21
Du X, Shi L, Cao W, et al. | PLoS One
Aim: To evaluate the add-on effect of CHM in the treatment of mild to moderate COVID-19.
CANDIDATE THERAPEUTICS
8/23/21
Sullivan BN, Fischer T | Front Aging Neurosci
Aim: To gain insight into the types of neurological complications associated with SARS-CoV-2 infection and their possible relationship with age, sex, COVID-19 severity, and comorbidities.
CLINICAL CHARACTERISTICS
8/23/21
An W, Kang J, Wang Q, et al. | J Infect Public Health
Aim: To systematically investigate the relationship between cardiac biomarkers and COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
8/23/21
Wei Y, Wei L, Liu Y, et al. | Infection
Aim: To estimate the central tendency and dispersion for incubation period of COVID-19 and, in turn, assess the effect of a certain length of quarantine for close contacts in active monitoring.
INFECTION CONTROL
8/23/21
Ghorbani SS, Taherpour N, Bayat S, et al. | J Med Virol
Aim: To review the evidence on the frequency and definitions of re-infection rates, recurrence, and hospital readmission following SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
8/23/21
Andreas M, Piechotta V, Skoetz N, et al. | Cochrane Database Syst Rev
Aim: To assess the efficacy and safety of pharmacological and non-pharmacological interventions for palliative symptom control in individuals with COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
8/23/21
Zace D, Hoxhaj I, Orfino A, et al. | Eur J Public Health
Aim: To identify strategies to manage mental health issues in healthcare workers during infectious disease outbreaks.
MENTAL HEALTH
8/23/21
Buselli R, Corsi M, Veltri A, et al. | Psychiatry Res
Aim: To ascertain the interventions put in place worldwide in reducing stress in HCWs during the COVID-19 outbreak. 
MENTAL HEALTH
8/23/21
Yan Q, Qiu D, Liu X, et al. | Front Pediatr
Aim: To examine the pooled prevalence of smell or taste dysfunctions among children with COVID-19.
CLINICAL CHARACTERISTICS
8/23/21
Wang J, Shi P, Chen D, et al. | Stem Cells Dev
Aim: To review the evidence on the safety and effectiveness of MSCs in the treatment of COVID-19-associated pneumonia patients
CANDIDATE THERAPEUTICS
8/23/21
Bhattacharyya A, Sarma P, Sharma DJ, et al. | Indian J Pharmacol
Aim: To review the evidence on COVID-19-associated mucormycosis.
CLINICAL CHARACTERISTICS
8/23/21
Mashayekhi F, Sairafianpour F, Mohammad AP, et al. | Int J Clin Pract
Aim: To review the evidence on presentations of severe potential life-threatening skin eruptions in COVID-19.
CLINICAL CHARACTERISTICS
8/23/21
Han T, Ma S, Sun C, et al. | Arch Med Res
Aim: To further explore queries about effects of anti-diabetic agents on mortality and poor composite outcomes of COVID-19 in diabetic patients.
CLINICAL CHARACTERISTICS
8/23/21
Oliaei S, SeyedAlinaghi S, Mehrtak M, et al. | Eur J Med Res
Aim: To systematically review the studies discussing hyperbaric oxygen therapy (HBOT) to examine its reported efficacy and adverse events in patients with COVID-19.
CANDIDATE THERAPEUTICS
8/23/21
Chiu N, Chi H, Tu Y, et al. | Expert Rev Vaccines
Aim: To review the evidence on the immunogenicity and reactogenicity of heterologous vaccination.
INFECTION CONTROL
8/23/21
Prajapat M, Handa V, Sarma P, et al. | Indian J Pharmacol
Aim: To review the different mutation strains (variant of concern [VOC] and variant of interest [VOI]) which were found in different countries such as the UK, Singapore, China, Germany, Vietnam, Western Africa, Dublin, Ireland, Brazil, Iran, Italy, France, America, and Philippines.
INFECTION CONTROL
8/23/21
Busch IM, Moretti F, Mazzi M, et al. | Psychotherapy and Psychosomatics
Aim: To comprehensively synthesize and quantify the psychological and psychosomatic symptoms of healthcare providers on the frontline of past epidemics/pandemics (i.e., Ebola, H1N1, SARS, MERS) and the current pandemic (i.e., COVID-19).
UPDATED
MENTAL HEALTH
8/18/21
 | NSW Health COVID-19 Critical Intelligence Unit
8/18/21
 | NSW Health COVID-19 Critical Intelligence Unit
8/18/21
Kourti A, Stavridou A, Panagouli E, et al. | Trauma Violence Abuse
Aim: To identify the international trends in domestic violence during the COVID-19 epidemic and to examine the possible differences among all population groups and different geographic areas worldwide.
MENTAL HEALTH
8/18/21
Tadakamadla J, Boccalari E, Rathore V, et al. | J Infect Public Health
Aim: To evaluate the evidence on the efficacy of mouth rinses on SARS-CoV-2 from in vitro studies.
CANDIDATE THERAPEUTICS
8/18/21
 | NSW Health COVID-19 Critical Intelligence Unit
8/18/21
 | COVID-END
Aim: To review the evidence on the efficacy and effectiveness of available COVID-19 vaccines for variants of concern.
UPDATED
8/17/21
Finsterer J, Scorza FA, Scorza C, et al. | Bosn J Basic Med Sci
Aim: To summarize and discuss the recent advances concerning the clinical presentation, pathophysiology, diagnosis, treatment, and outcomes of SARS-CoV-2 associated cranial nerve mononeuropathies or polyneuropathies. 
CLINICAL CHARACTERISTICS
8/17/21
Ridjab DA, Ivan I, Budiman F, et al. | Medicine
Aim: To evaluate risk of PR prolongation, QRS widening, and QT prolongation from lopinavir, ritonavir, atazanavir, and saquinavir.
CANDIDATE THERAPEUTICS
8/17/21
Walsh S, Chowdhury A, Braithwaite V, et al.  | BMJ Open
Aim: To summarise observational evidence of the effect of school closures and school reopenings on SARS-CoV-2 community transmission.
UPDATED
INFECTION CONTROL
8/17/21
Kyriazopoulou E, Huet T, Cavalli G, et al. | Lancet Rheumatol
Aim: To assess the effect of anakinra treatment on mortality in patients admitted to hospital with COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
8/17/21
Zheng HL, Guo ZL, Wang ML, et al. | Environ Sci Pollut Res Int
Aim: To review the evidence on the association between COVID-19 (coronavirus disease 2019) transmission and meteorological factors.
INFECTION CONTROL
8/17/21
Liu CY, Berlin J, Kiti MC, et al. | Epidemiology
Aim: To synthesize empirical data on the changing social contact patterns during the COVID-19 pandemic. 
INFECTION CONTROL
8/17/21
Shanbehzadeh M, Kazemi-Arpanahi H, Kalkhajeh SG, et al. | J Educ Health Promot
Aim: To identify the telemedicine applications in the COVID-19 pandemic (tele-COVID) according to interaction modes, transmission modalities, and disease categories.
INFECTION CONTROL
8/17/21
Wagner C, Griesel M, Mikolajewska A, et al. | Cochrane Database Syst Rev
Aim: To assess whether systemic corticosteroids are effective and safe in the treatment of people with COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
8/17/21
Li F, Jiang Y, Yue B, et al. | Medicine
Aim: To evaluate the supportive effects of frequently used traditional Chinese medicine (TCM) for the treatment of coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
8/16/21
Ismail II, Salama S | J Neurol
Aim: To investigate the available evidence regarding the different types of CNS demyelination in association with SARS-CoV-2 infection, and the proposed pathophysiological mechanisms in these cases.
CLINICAL CHARACTERISTICS
8/16/21
Sunjaya AP, Allida SM, Di Tanna GL, et al. | Eur Respir J
Aim: To review the evidence on whether people with asthma at a higher risk of being infected, hospitalised or of poorer clinical outcomes from COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
8/16/21
Zinellu A, Mangoni AA | J Nephrol
Aim: To review the evidence on the effectiveness of serum cystatin C in COVID-19 in treating COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
8/16/21
Karaoulanis SE, Christodoulou NG | Psychiatriki
Aim: To clarify whether patients with schizophrenia spectrum disorders are at greater risk for poor COVID-19 outcomes.
CLINICAL CHARACTERISTICS
8/16/21
Walsh KA, Tyner B, Broderick N, et al. | Rev Med Virol
Aim: To summarize the evidence regarding the effectiveness of public health measures at preventing the transmission of SARS-CoV-2 at mass gatherings.
INFECTION CONTROL
8/16/21
Cui Y, Sun Y, Sun J, et al. | Infect Dis Ther
Aim: To explore the beneficial effect of corticosteroids, particularly in pulse methylprednisolone use in patients with COVID-19.
CANDIDATE THERAPEUTICS
8/16/21
Alsagaff MY, Oktaviono YH, Dharmadjati BB, et al.  | J Arrythm
Aim: To evaluate the latest evidence on the association of ECG on admission and the poor outcomes in COVID?19.
CLINICAL CHARACTERISTICS
8/16/21
Chekole YA, Abate SM | Ann Med Surg
Aim: To assess the global prevalence and determinants of mental health disorders.
UPDATED
MENTAL HEALTH
8/16/21
Scquizzato T, D'Amico F, Rocchi M, et al. | Prehosp Emerg Care
Aim: To analyse how the pandemic impacted the system-of-care of out-of-hospital cardiac arrest.
UPDATED
INFECTION CONTROL
8/16/21
Chawla N, Tom A, Sen MS, et al. | Indian J Psychol Med
Aim: To appraise the literature from across the globe on the psychological impact of COVID-19 and its associated situations, like social isolation and quarantine, on children and adolescents.
MENTAL HEALTH
8/16/21
Maiese A, Manetti AC, Bosetti C, et al. | Brain Pathol
Aim: To review the evidence on the neuropathological features of COVID-19.
CLINICAL CHARACTERISTICS
8/16/21
Abate V, Casoria A, Rendina D, et al. | Semin Thromb Hemost
Aim: To describe the prevalence and the clinical characteristics of SMH in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/16/21
Brummer LE, Katzenschlager S, Geaddert M, et al.  | PLoS One
Aim: To assess the clinical accuracy (sensi-tivity and specificity) of commercially available Ag-RDTs.
UPDATED
DIAGNOSTICS
8/16/21
Suárez-González A, Rajagopalan J, Livingston G, et al. | EClinicalMedicine
Aim: To examine and summarise the global research evidence describing the effect of Covid-19 isolation measures on the health of people living with dementia.
UPDATED
MENTAL HEALTH
8/13/21
Kazemi SN, Hajikhani B, Didar H, et al. | PLoS One
Aim: To understand better the potential effects of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on fetal loss in infected mothers presented with abortion following this infection.
CLINICAL CHARACTERISTICS
8/13/21
AbdelHamid S, Refaat AA, Benjamin AM, et al. | Environ Sci Pollut Res Int
Aim: To study the impact of host or viral epigenetic modulation on COVID-19 infection susceptibility and/or outcome.
UPDATED
CLINICAL CHARACTERISTICS
8/13/21
Llamas M, Garo ML, Giovanella L | Clin Chem Lab Med
Aim: To assess the prognostic role of fT3 serum levels in patients with COVID-19.
CLINICAL CHARACTERISTICS
8/13/21
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk of transmission of COVID-19 within post-secondary institutions and the strategies to mitigate on-campus outbreaks?
UPDATED
8/12/21
Sah P, Fitzpatrick MC, Zimmer CF, et al. | Proc Natl Acad Sci USA
Aim: To review the evidence on laboratory-confirmed infections to estimate the percentage of SARS-CoV-2 infections that are truly asymptomatic. 
CLINICAL CHARACTERISTICS
8/12/21
Kloypan C, Saesong M, Sangsuemoon J, et al. | Eur J Clin Invest
Aim: To investigate the efficacy of CP vs standard treatment/non-CP on clinical outcomes in COVID-19 patients.
CANDIDATE THERAPEUTICS
8/12/21
Sen S, Kanna NB, Kumar J, et al. | Int Ophthalmol
Aim: To summarize all retinal manifestations secondary to COVID-19 disease recorded till date since the beginning of the pandemic.
CLINICAL CHARACTERISTICS
8/12/21
Diaz-Arocutipa C, Melgar-Talavera B, Alvarado-Yarasca A, et al. | 
Aim: To examine the effect of statins use on mortality in COVID-19 patients.
CANDIDATE THERAPEUTICS
8/12/21
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the role of daycares and schools in the transmission of COVID-19.
UPDATED
8/11/21
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. | Sci Rep
Aim: To identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage.
UPDATED
CLINICAL CHARACTERISTICS
8/10/21
Lazzari C, Rabottini M | Int J Psychiatry Clin Pract
Aim: To review studies that approach the risk of dementia in older people with SIFL.
MENTAL HEALTH
8/10/21
Chung EY, Palmer SC, Natale P, et al. | Am J Kidney Dis
Aim: To assess the incidence and outcomes of COVID-19 in people with CKD.
CLINICAL CHARACTERISTICS
8/10/21
Yang Y, Cai Z, Zhang J | Front Endocrinol
Aim: To determine the association between insulin injection and the outcomes of COVID-19.
CLINICAL CHARACTERISTICS
8/10/21
de Almeida CARPN, de Almeida GARPN, de Carvalho MRCT, et al. | Brazilian Journal of Health Review
Aim: To review the evidence on the mental health aspects of health professionals during the COVID-19 pandemic.
MENTAL HEALTH
8/10/21
Qian Z, Lu S, Luo X, et al. | Front Med
Aim: To summarize the current existing evidence on the outcome of critically ill patients with COVID-19 as well as to evaluate the effectiveness of clinical interventions.
CLINICAL CHARACTERISTICS
8/10/21
Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, et al. | J Neurol Sci
Aim: To review the reported cases of CVST and VITT following the COVID-19 vaccination.
INFECTION CONTROL
8/9/21
Athanasios A, Daley I, Patel A, et al. | Eur Neurol
Aim: To review the prevalence of cerebrovascular accident in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Ingram C, Downey V, Roe M, et al.  | Int J Environ Res Public Health
Aim: To synthesize evidence assessing the effectiveness of COVID-19 IPC measures implemented in global workplace settings.
INFECTION CONTROL
8/9/21
Conti V, Corbi G, Sellitto C, et al.  | J Pers Med
Aim: To review and assess the effectiveness of TCZ in reducing the mortality rate in COVID-19 patients.
UPDATED
CANDIDATE THERAPEUTICS
8/9/21
Kovoor JG, Tivey DR, Ovenden CD, et al. | BJS Open
Aim: To characterize surgical evolution following COVID-19. 
UPDATED
INFECTION CONTROL
8/9/21
Alves VP, Casemiro FG, Araujo BG, et al. | Int J Environ Res Public Health
Aim: To evaluate the factors associated with mortality of elderly Brazilians and Italians diagnosed with the new coronavirus who resided in institutions or who were hospitalized as a result of the disease.
UPDATED
CLINICAL CHARACTERISTICS
8/9/21
Gómez CA, Sun CK, Tsai IT, et al. | Sci Rep
Aim: To determine, in patients with coronavirus disease 2019 (COVID-19) infection, the associations of pulmonary embolism (PE) with mortality and risk factors for PE as well as the therapeutic benefit of anticoagulant prophylaxis.
UPDATED
CLINICAL CHARACTERISTICS
8/9/21
Cabreira V, Abreu P, Soares-Dos-Reis R, et al. | Vaccines
Aim: To review the evidence on the incidence and outcomes of COVID-19 in MS patients on DMTs.
CLINICAL CHARACTERISTICS
8/9/21
Olaya B, Pérez-Moreno M, Bueno-Notivol J, et al. | J Clin Med
Aim: To examine the global prevalence of anxiety and depression among HCW during the COVID-19 outbreak.
MENTAL HEALTH
8/9/21
Ho TC, Chang CC, Chan HP, et al. | Pathogens
Aim: To analyze the pulmonary findings of [18F]FDG PET/CT on asymptomatic COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Sadiq Z, Rana S, Mahfoud Z, et al. | Clin Imaging
Aim: To determine the most common appearances of lung abnormalities in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Gualano MR, Sinigaglia T, Lo Moro G, et al. | Int J Environ Res Public Health
Aim: To evaluate the burnout prevalence among healthcare workers (HCWs) in intensive care units (ICUs) and emergency departments (EDs) during the COVID-19 pandemic.
MENTAL HEALTH
8/9/21
Gourret Baumgart J, Kane H, El-Hage W, et al. | Int J Environ Res Public Health
Aim: To document the early impacts of the COVID-19 health crisis on psychiatry and mental health sectors.
MENTAL HEALTH
8/9/21
Prada L, Santos CD, Baião RA, et al. | J Clin Pharmacol
Aim: To systematically evaluate the risk of SARS-CoV-2 infection and mortality and the risk of severe coronavirus disease 2019 (COVID-19) associated with previous exposure to NSAIDs. 
UPDATED
CLINICAL CHARACTERISTICS
8/6/21
Guo S, Yan N, Liu F, et al. | SSRN
Aim: To provide effective exercise interventions for people confined to their homes by social isolation measures during the COVID-19 epidemic, so they can cope with depression timely.
8/5/21
Batra K, Sharma M, Batra R, et al. | Healthcare
Aim: To present collective evidence discussing the psychological impact of COVID-19 among college students.
UPDATED
MENTAL HEALTH
8/5/21
Zhang Z, Ai G, Chen L, et al. | BMC Infect Dis
Aim: To explore the association of immunological features with COVID-19 severity.
CLINICAL CHARACTERISTICS
8/5/21
Clark M | CADTH
Aim: To review the evidence on the effectiveness of breath tests to detect SARS-CoV-2.
8/5/21
Chen C, Chen W, Hsu C, et al. | Int Immunopharmacol
Aim: To investigate the clinical efficacy and safety of Janus kinase (JAK) inhibitors for COVID-19 patients.
UPDATED
CANDIDATE THERAPEUTICS
8/5/21
dos Santos MF, dos Santos Rodrigues JF | Nursing (Sao Paulo)
Aim: To analyze the main psychological impacts resulting from quarantine and social isolation .
MENTAL HEALTH
8/5/21
Rains LS, Johnson S, Barnett P, et al. | Soc Psychiatry Psychiatr Epidemiol
Aim: To map early impacts of the pandemic on people with pre-existing mental health conditions and services they use, and to identify individual and service-level strategies adopted to manage these.
UPDATED
MENTAL HEALTH
8/5/21
Özlü?en B, Kozan ?, Akcan RE, et al. | Eur J Clin Microbiol Infect Dis
Aim: To review the evidence on the effectiveness of Favipiravir on the fatality and the requirement of mechanical ventilation for the treatment of moderate to severe COVID-19 patients.
CANDIDATE THERAPEUTICS
8/5/21
Kumar S, Saurabh MK, Maharshi V | J Adv Pharm Technol Res
Aim: To review and compare the available early phase clinical data of COVID-19 vaccine candidates which have reached phase 3 of clinical development. 
INFECTION CONTROL
8/5/21
Nasution LA, Fitriana LA | Jurnal Pendidikan Keperawatan Indonesia
Aim: To identify the factors that influence the increase in incidence in women. 
MENTAL HEALTH
8/5/21
Hong S, Kim H, Park MK | Int J Ment Health Nurs
Aim: To synthesize the findings of empirical studies reporting the post?traumatic stress symptoms in the general population during the coronavirus pandemic.
MENTAL HEALTH
8/5/21
Chou R, Dana T, Jungbauer R, et al. | Ann Intern Med
Aim: To examine the effectiveness of N95, surgical, and cloth masks in community and health care settings for preventing respiratory virus infections, and effects of reuse or extended use of N95 masks.
UPDATED
8/5/21
Buwade J | Int J Indian Psychol
Aim: To review the evidence on the mental health effects of COVID-19 Pandemic.
MENTAL HEALTH
8/5/21
Ansems K, Grundeis F, Dahms K, et al. | Cochrane Database Syst Rev
Aim: To assess the effects of remdesivir compared to placebo or standard care alone on clinical outcomes in hospitalised patients with SARS?CoV?2 infection.
CANDIDATE THERAPEUTICS
8/5/21
Sahu AK, Mathew R, Bhat R, et al. | QJM
Aim: To assess effect of steroids in mild COVID-19 patients.
UPDATED
CANDIDATE THERAPEUTICS
8/4/21
Tsheten T, Clements ACA, Gray DJ, et al. | BMC Infect Dis
Aim: To collate and synthesise current knowledge on the clinical features and outcomes of COVID-19 and dengue virus co-infection.
CLINICAL CHARACTERISTICS
8/4/21
Yadav AK, Ghosh S, Dubey S | Med J Armed Forces India
Aim: To summarize and synthesize evidence from all available case series and case reports published on re-positive COVID-19 cases.
CLINICAL CHARACTERISTICS
8/4/21
Cosentino G, Todisco M, Hota N, et al. | Eur J Neurol
Aim: To review the evidence on neuropathological findings and their clinical correlations in COVID-19.
CLINICAL CHARACTERISTICS
8/4/21
Kow CS, Hasan SS | Am J Cardiovasc Drugs
Aim: To summarize the existing evidence on the effect of statins on the clinical outcomes of patients with COVID-19.
CANDIDATE THERAPEUTICS
8/3/21
Yadav AK, Ghosh S, Dubey S | Med J Armed Forces India
Aim: To summarize and synthesize evidence from all available case series and case reports published on re-positive COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
8/3/21
Wang JG, Zhong ZJ, Li M, et al. | Biochem Res Int
Aim: To describe the clinical symptoms, laboratory findings, treatment, and outcomes of coronavirus disease 2019-related multisystem inflammatory syndrome in children to provide a reference for clinical practice.
CLINICAL CHARACTERISTICS
8/3/21
Abate SM, Mantefardo B, Nega S, et al. | Ann Med Surg
Aim: To determine the prevalence, determinants, and outcomes of acute myocardial injury. 
UPDATED
CANDIDATE THERAPEUTICS
8/3/21
Li Y, Wang A, Wu Y, et al. | Front Psychol
Aim: To synthesize the existing evidence of the prevalence of mental health status during the epidemic and provide the basis for mental health education.
MENTAL HEALTH
8/3/21
Taheri Soodejani M, Basti M, Tabatabaei SM, et al. | Int J Mol Epidemiol Genet
Aim: To investigate published literature about the association between measles, mumps, and rubella (MMR) vaccine and COVID-19. 
CLINICAL CHARACTERISTICS
8/3/21
Moore N, Bosco-Levy P, Thurin N, et al. | Drug Saf
Aim: To collate the evidence regarding the possible risks associated with the use of NSAIDs in COVID-19.
CLINICAL CHARACTERISTICS
8/3/21
Yuwono Soeroto A, Purwiga A, Alam A, et al. | Eur Rev Med Pharmacol Sci
Aim: To investigate the role of Convalescent Plasma (CP) in reducing mortality of COVID-19 patients.
CANDIDATE THERAPEUTICS
8/3/21
Ferreira de Araújo JL, Menezes D, Saraiva-Duarte JM, et al. | Rev Med Virol
Aim: To review genetic association studies evaluating Covid-19 severity or susceptibility to SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
8/3/21
Wu D, Wang VY, Chen YH, et al. | Auris Nasus Larynx
Aim: To determine how initial symptoms of OGD can be used to screen patients for COVID-19 laboratory testing.
CLINICAL CHARACTERISTICS
8/2/21
Okoli G, Rabbani R, Al-Juboori A, et al. | Expert Rev Anti Infect Ther
Aim: To better inform clinical practice, we summarized the findings from randomized controlled trials (RCTs) of antivirals for COVID-19.
CANDIDATE THERAPEUTICS
8/2/21
Katzenschlager S, Zimmer AJ, Gottschalk C, et al. | PLoS One
Aim: To assess demographic, laboratory and clinical indicators as predictors for severe courses of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
8/2/21
Bassetti M, Giacobbe DR, Bruzzi P, et al. | Infect Dis Ther
Aim: To develop evidence-based guidance for the clinical management of adult patients with coronavirus disease 2019 (COVID-19) outside intensive care units.
CANDIDATE THERAPEUTICS
8/2/21
Ansari Ramandi MM, Yarmohammadi H, Beikmohammadi S, et al. | J Cardiovasc Thorac Res
Aim: To gather all possible cardiovascular manifestations of the coronavirus family in the literature. 
UPDATED
CLINICAL CHARACTERISTICS
8/2/21
Cherrie JW, Cherrie MPC, Smith A, et al. | Ann Work Expo Health
Aim: To evaluate the evidence for air and surface contamination of workplace environments with SARS-CoV-2 RNA and the quality of the methods used to identify actions necessary to improve the quality of the data.
INFECTION CONTROL
8/2/21
Feng Z, Yang J, Xu M, et al. | Clin Nutr ESPEN
Aim: To synthesize the available evidence from current existing RCTs and evaluate the impacts of DSs in people with COVID-19.
CANDIDATE THERAPEUTICS
8/2/21
Angamo MT, Mohammed MA, Peterson GM | Infection
Aim: To synthesise the best available evidence on the effectiveness and safety of remdesivir in the treatment of moderate to severe COVID-19.
CANDIDATE THERAPEUTICS
8/2/21
McGowan VJ, Lowther HJ, Meads C | BMJ Open
Aim: To systematically review all published and unpublished evidence on the impact of the COVID-19 pandemic on the health and well-being of UK sexual and gender minority people.
UPDATED
MENTAL HEALTH
8/2/21
Y?lmaz B, Azak M, ?ahin N | World J Psychiatry
Aim: To determine the mental health status of parents with children diagnosed with ASD in the COVID-19 pandemic.
MENTAL HEALTH
8/2/21
Cammarota G, Esposito T, Azzolina D, et al. | Crit Care
Aim: To summarize the evidence on clinically relevant outcomes in COVID-19 patients supported by NIV outside the ICU.
UPDATED
CANDIDATE THERAPEUTICS
8/2/21
Irfan O, Li J, Tang K, et al. | J Glob Health
Aim: To assess transmission and risks for SARS-CoV-2 in children (by age-groups or grades) in community and educational-settings compared to adults.
INFECTION CONTROL
8/2/21
Mittal N, Mittal R, Gupta MC, et al.  | J Family Med Prim Care
Aim: To evaluate the therapeutic potential of CQ/HCQ given alone and in combination with azithromycin for treatment of confirmed COVID-19 infection caused by SARS-CoV-2, in comparison to standard management or other drugs.
UPDATED
CANDIDATE THERAPEUTICS
8/2/21
SeyedAlinaghi S, Karimi A, MohsseniPour M, et al.  | Immun Inflamm Dis
Aim: To investigate the impact of COVID-19 on patients infected with HIV.
CLINICAL CHARACTERISTICS
8/2/21
Ghasemian R, Shamshirian A, Heydari K, et al. | Int J Clin Pract
Aim: To review the evidence on the role of vitamin D in COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
8/2/21
Mao G, Fernandes-Jesus M, Ntontis E, et al. | BMC Public Health
Aim: To review the evidence on COVID-19 volunteering both at the UK national level and the more local community level.
7/29/21
Ceban F, Nogo D, Carvalho IP, et al. | JAMA Psychiatry
Aim: To assess whether preexisting mood disorders are associated with a higher risk of COVID-19 susceptibility, hospitalization, severe complications, and death.
UPDATED
CLINICAL CHARACTERISTICS
7/29/21
de Candia P, Prattichizzo F, Garavelli S, et al. | iScience
Aim: To examine the effect of convalescent plasma in patients with COVID-19.
CANDIDATE THERAPEUTICS
7/29/21
Wu Q, Dudley MZ, Chen X, et al. | BMC Med
Aim: To provide comprehensive overview of the safety profile of COVID-19 vaccines by using meta-analysis technique.
INFECTION CONTROL
7/29/21
Zinellu A, Paliogiannis P, Carru C, et al. | Adv Med Sci
Aim: To review the evidence on the international normalized ratio (INR) in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/29/21
Nagraj S, Karia R, Hassanain S, et al. | Indian J Crit Care Med
Aim: To provide insight into the outcome of extracorporeal membrane oxygenation (ECMO) and invasive mechanical ventilation use in critically ill COVID-19 patients.
CANDIDATE THERAPEUTICS
7/29/21
Shenoy S | World J Crit Care Med
Aim: To identify whether quantitative SARS-CoV-2 viral load assay correlates with clinical outcome in COVID-19 infections.
CLINICAL CHARACTERISTICS
7/29/21
Mohsenpour A, Bozorgmehr K, Rohleder S, et al. | EClinicalMedicine
Aim: To review the evidence on SARS-Cov-2 infection, transmission, outcomes of disease, effects of non-pharmaceutical interventions (NPI), and the effectiveness of strategies for infection prevention and control (IPC).
UPDATED
INFECTION CONTROL
7/29/21
Tobaiqy M, Qashqary M, Al-Dahery S, et al. | Infection Prevention in Practice
Aim: To report any evidence of therapeutics used for the management of patients with COVID-19 in clinical practice since emergence of the virus.
CANDIDATE THERAPEUTICS
7/28/21
Lin C, Lin Y | Arch Clin Psychiatry
Aim: To synthesize the evidence of correlation between demographic factors, social media exposure, stressors and anxiety and depression status in the early phase of COVID-19.
7/28/21
Raoofi S, Pashazadeh Kan F, Rafiei S, et al. | BMJ Support Palliat Care
Aim: To systematically review the existing literature examining the prevalence of anxiety among hospital staff and identifying the contributing factors to address the complications of this disorder.
UPDATED
MENTAL HEALTH
7/28/21
Fond G, Nemani K, Etchecopar-Etchart D, et al.  | JAMA Psychiatry
Aim: To determine whether patients with mental health disorders were at increased risk of COVID-19 mortality compared with patients without mental health disorders.
UPDATED
MENTAL HEALTH
7/28/21
Pacheco F, Sobral M, Guiomar R, et al. | Syst Res Behav Sci
Aim: To review evidence regarding the impact of COVID-19 on breastfeeding plans and how these relate to women's psychological outcomes.
7/28/21
Zhu Y, Xing W, Wang H, et al. | Infect Dis
Aim: To analyze the differences of the baseline characteristics and therapeutic features between STEMI patients admitted before and after the start of the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
7/28/21
Akinbi A, Forshaw M, Blinkhorn V | Health Info Sci
Aim: To review the evidence on the current challenges and application of contact tracing apps in the fght against the COVID-19 pandemic.
7/28/21
Limongi JE, de Oliviera SV | Vigilância Sanitária em Debate
Aim: To conduct a systematic review of the literature on the application of the concepts of One Health in the current pandemic context of COVID-19.
7/28/21
Brabicoski CV, Floriano LMS, Skupien SV, et al. | Braz J Dev
Aim: To review the evidence on the impact of the COVID-19 pandemic on mental health and strategies to cope at the university level.
7/28/21
Bazyar J, Chehreh R, Sadeghifar J, et al.  | Prehosp Disaster Med
Aim: To review the evidence on the effect of the SARS-CoV-2 pandemic on sexual function and domestic violence in the world.
MENTAL HEALTH
7/28/21
Clark R, Palmer J, Pearce-Smith N, et al. | Public Health England
Aim: To identify and assess direct evidence from the COVID-19 outbreak on the effectiveness of face coverings when used in the community, and the efficacy of different types of face coverings.
7/28/21
Orsini MA, do Nascimento JSF, Azizi M, et al. | Revista de Saúde
Aim: To review the evidence on the effects of the pandemic on sleep disorders, with insomnia being the most related. 
7/28/21
Popp M, Stegemann M, Metzendorf M, et al. | Cochrane Database Syst Rev
Aim: To assess the efficacy and safety of ivermectin compared to no treatment, standard of care, placebo, or any other proven intervention for people with COVID?19 receiving treatment as inpatients or outpatients, and for prevention of an infection with SARS?CoV?2 (postexposure prophylaxis).
7/28/21
Azab MA, Hasaneen SF, Hanifa H, et al. | Interdiscip Neurosurg
Aim: To report a case manifested as post-COVID-19 optic neuritis, in addition to make a quantitative analysis (meta-analysis) for the published similar case reports around the world.
CLINICAL CHARACTERISTICS
7/28/21
Belluco S, Mancin M, Marzoli F, et al. | Eur J Epidemiol
Aim: To estimate SARS-CoV-2 prevalence on inanimate surfaces, identifying risk levels according to surface characteristics.
INFECTION CONTROL
7/27/21
Goswami J, MacArthur TA, Sridharan M, et al. | Shock
Aim: To summarize and discuss the current literature on laboratory coagulation disruptions associated with COVID-19 and the clinical effects of thromboembolic events in COVID-19. 
CLINICAL CHARACTERISTICS
7/27/21
Drissi N, Ouhbi S, Marques G, et al. | Telemed J E Health
Aim: To review the evidence on developed e-mental health interventions for HCWs during the COVID-19 pandemic.
MENTAL HEALTH
7/27/21
Szarpak L, Rafique Z, Gasecka A, et al. | Cardiol J
Aim: To establish a connection between vitamin D status and COVID-19 infection.
CLINICAL CHARACTERISTICS
7/27/21
Lieneck C, Herzog B, Krips R | Healthcare
Aim: To identify and classify facilitators and barriers related to the delivery of routine care during the COVID-19 global pandemic.
INFECTION CONTROL
7/27/21
Adamidi ES, Mitsis K, Nikita KS, et al. | Comput Struct Biotechnol J
Aim: To review the evidence on Artificial Intelligence techniques developed and validated for screening, diagnosis, and prognosis of the coronavirus disease 2019. 
DIAGNOSTICS
7/27/21
Zhao R, Su Z, Komissarov AA, et al. | Front Immunol
Aim: To explore the relationships between the plasma D-dimer level on admission with demographics, laboratory tests, fatal cardiopulmonary function, radiology, interventions, complications, and outcomes.
CLINICAL CHARACTERISTICS
7/27/21
Shafiabadi Hassani N, Talakoob H, Karim H, et al. | J Magn Reson Imaging
Aim: To systematically review the main cardiac MRI findings in COVID-19 adult survivors.
CLINICAL CHARACTERISTICS
7/27/21
Rastogi A, Dogra H, Jude EB, et al. | Diabetes Metab Syndr
Aim: To identify the prevalence, risk factors and outcomes of lower extremity ischemic complications.
CLINICAL CHARACTERISTICS
7/27/21
Fan KS, Ghani SA, Machairas N, et al. | BMJ Open
Aim: To assess the quality of information of top indexed websites that discuss information, prevention or treatment of COVID-19.
7/27/21
Silvestre FJ, Martinez-Herrera M, Márquez-Arrico CF, et al. | J Clin Exp Dent
Aim: To offer a clinical protocol to reduce the risk of infection of COVID-19 in dental settings.
INFECTION CONTROL
7/27/21
Mehraeen E, Najafi Z, Hayati B, et al. | Infect Disord Drug Targets
Aim: To describe the recent treatment strategies to treat COVID-19 patients.
CANDIDATE THERAPEUTICS
7/27/21
Guo S, Kaminga AC, Xiong J, et al. | Front Public Health
Aim: To evaluate the prevalence of depression among college students in China during the lockdown due to the COVID-19 pandemic and assess their coping strategies. 
MENTAL HEALTH
7/27/21
Yin B, Bi YM, Sun L, et al. | Front Public Health
Aim: To evaluate the efficacy of integrated medicine therapy for patients with COVID-19.
INFECTION CONTROL
7/27/21
Kusumawardhani N, Dewi IP, Dharmadjati BB, et al. | J Saudi Heart Assoc
Aim: To systematically review and meta-analysis ECMO use in COVID-19 patients.
CANDIDATE THERAPEUTICS
7/27/21
Ford N, Holmer HK, Chou R, et al. | EClinicalMedicine
Aim: To summarize the study designs, outcomes, and key quality indicators of using ecological data to evaluate the association between mask wearing and COVID-19 outcomes. 
INFECTION CONTROL
7/27/21
Tarun V, Anurag T, Yugal K, et al. | J Anthrosc Jt Surg
Aim: To review various operating room measures which are recommended and being followed to carry out orthopaedic surgeries in the current scenario of COVID 19 pandemic. 
INFECTION CONTROL
7/27/21
Xu H, Stjernswärd S, Glasdam S, et al. | Int J Nurs Stud Adv
Aim: To explore the psychosocial experiences of frontline nurses working in hospital-based settings during the COVID-19 pandemic.
UPDATED
MENTAL HEALTH
7/27/21
Zahedi M, Yousefi M, Abounoori M, et al. | Iran J Med Sci
Aim: To establish the characteristics of liver function tests in COVID-19 patients.
CLINICAL CHARACTERISTICS
7/27/21
Zhang K, Zhang X, Ding W, et al. | Front Med
Aim: To evaluate the prognostic accuracy of the NEWS2 on predicting clinical deterioration for patients with COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
7/27/21
Sun P, Wang M, Song T, et al.  | Front Psychol
Aim: To determine the psychological impact of COVID-19 pandemic on health care workers.
MENTAL HEALTH
7/26/21
Karimi A, Nowroozi A, Alilou S, et al. | Urol J
Aim: To study the effect of androgen deprivation therapy (ADT) on COVID-19 in patients with prostate cancer.
UPDATED
CLINICAL CHARACTERISTICS
7/26/21
Shah K, Upadhyaya M, Kandre Y, et al. | QJM
Aim: To provide comprehensive overview of epidemiological, clinical and biomarker profile of COVID-19 infection in pediatric population.
CLINICAL CHARACTERISTICS
7/26/21
Timbrook TT, Hueth KD, Ginocchio CC | Diagn Microbil Infect Dis
Aim: To review the evidence on the impact of BioFire® FilmArray® Pneumonia Panel in detecting bacteria and clinical management among critically ill COVID-19 patients admitted to the ICU.
7/26/21
Purja S, Shin H, Lee JY, et al. | Arch Pharm Res
Aim: To examine the association between COVID-19 severity and loss of smell (LOS) in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/26/21
Shah K, Varna PV, Pandya A, et al. | QJM
Aim: To study the relationship between vitamin D level, risk and severity of COVID-19 infection in pediatric population through systematic review.
CLINICAL CHARACTERISTICS
7/26/21
Chen X, Chen Z, Azman AS, et al.  | Clin Infect Dis
Aim: To summarize the evidence on neutralization ability against various SARS-CoV-2 variants among those previously infected with strains from the original SARSCoV-2 lineage and those who have been vaccinated
UPDATED
INFECTION CONTROL
7/26/21
Conde-Agudelo A, Romero R | Am J Obstet Gynecol
Aim: To examine the relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy and the risk of preeclampsia.
UPDATED
CLINICAL CHARACTERISTICS
7/26/21
Ferro A, Kotecha S, Auzinger G, et al. | Br J Oral Maxillofac Surg
Aim: To determine the cumulative incidence of complications, mortality, time to decannulation and ventilatory weaning.
CLINICAL CHARACTERISTICS
7/26/21
Zaffanello M, Piacentini G, Nosetti L, et al. | Thromb Res
Aim: To review the literature for thrombotic complications in children with COVID-19 infection and MIS-C.
CLINICAL CHARACTERISTICS
7/23/21
Ghidini S, Gasperetti A, Winterton D, et al. | Int J Cardiovasc Imaging
Aim: To summarize current knowledge on TTE-based RV assessment in COVID-19.
CLINICAL CHARACTERISTICS
7/23/21
Garcia-Fernandez FJ | Research Square
Aim: To review the evidence on the use of transcription-mediated amplification assay to diagnose COVID-19.
DIAGNOSTICS
7/23/21
Moradi G, Gholami F, Rasouli MA, et al. | Med J Islam Repub Iran
Aim: To determine possible scenarios of Coronavirus 2019 (COVID-19) iceberg using published articles.
CLINICAL CHARACTERISTICS
7/23/21
O'Byrne L, Webster KE, MacKeith S, et al. | Cochrane Database Syst Rev
Aim: To assess the effects (benefits and harms) of interventions that have been used, or proposed, to treat persisting olfactory dysfunction due to COVID-19 infection.
CANDIDATE THERAPEUTICS
7/22/21
McGrowder DA, Miller F, Cross MA, et al. | Diseases
Aim: To review the evidence on abnormal liver biochemistry tests in COVID-19 and the possible pathogenesis involved.
UPDATED
CLINICAL CHARACTERISTICS
7/22/21
Zhang D, Huang WJ, Lan MQ | Eur Rev Med Pharmacol Sci
Aim: To systematically review the role of SAA levels in distinguishing among patients with mild, severe, and critical COVID-19.
CLINICAL CHARACTERISTICS
7/22/21
Dioguardi M, Cazzolla AP, Arena C, et al. | Pediatr Rep
Aim: To summarize aspects of innate immunity by focusing on the role of ACE2 expression and viral infections in children in modulating the antibody response to SARS-CoV-2 infection. 
CLINICAL CHARACTERISTICS
7/22/21
Ganesh A, Reis IR, Varma M, et al. | Can J Neurol Sci
Aim: To review the evidence on the various neurological and atypical HEENT manifestations of COVID-19.
CLINICAL CHARACTERISTICS
7/22/21
Noori M, Nejadghaderi SA, Arshi S, et al. | Rev Med Virol
Aim: To systematically review the most recent in vitro studies evaluating the effectiveness of BNT162b2 and mRNA-1273 induced neutralizing antibodies against SARS-CoV-2 variants of concern.
CANDIDATE THERAPEUTICS
7/22/21
Zhou Y, O'Leary TJ | PLoS One
Aim: To compare the sensitivity of nasal and nasopharyngeal swabs against a composite reference standard for the initial diagnosis of SARS-CoV-2 infection in ambulatory patients.
UPDATED
DIAGNOSTICS
7/22/21
Zuin M, Gentili V, Cervellati C, et al. | Infect Dis Rep
Aim: To investigate the possible difference in the SARS-CoV-2 viral load between asymptomatic and symptomatic COVID-19 patients.
CLINICAL CHARACTERISTICS
7/21/21
Snehota M, Vlckova J, Cizkova K, et al. | Bratisl Lek Listy
Aim: To review the evidence on people´s intention to receive a vaccine against COVID-19.
INFECTION CONTROL
7/21/21
Scappaticcio L, Maiorino MI, Iorio S, et al. | J Endocrinol Invest
Aim: To systematically collect the literature data on the characteristics of those thyroid operations performed and to assess the safety/risks associated with thyroid surgery during the COVID-19 pandemic.
INFECTION CONTROL
7/20/21
Kepczynski CM, Genigeski JA, Koski RR, et al. | J Am Pharm Assoc
Aim: To identify and compare at-home diagnostic tests that have been granted Emergency Use Authorizations (EUAs) and convey details about COVID-19 diagnostic tests, including regulatory information, pertinent to pharmacy practice.
DIAGNOSTICS
7/20/21
Gupta S, Jawanda MK, Taneja N, et al. | J Clin Neurosci
Aim: To evaluate the reported cases of COVID-19 positive patients, presented with Bell's palsy as the only major neurological manifestation, and to investigate the association of SARS-CoV2 and Bell's palsy.
CLINICAL CHARACTERISTICS
7/20/21
Kulkarni AV, Tevethia HV, Premkumar M, et al. | EClinicalMedicine
Aim: To analyse the outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in LT recipients.
CLINICAL CHARACTERISTICS
7/20/21
Vai B, Mazza MG, Delli Colli C, et al. | Lancet Psychiatry
Aim: To assess the specific risks of COVID-19-related mortality, hospitalisation, and intensive care unit (ICU) admission associated with any pre-existing mental disorder, and specific diagnostic categories of mental disorders, and exposure to psychopharmacological drug classes.
UPDATED
CLINICAL CHARACTERISTICS
7/20/21
Cirillo N | J Infect Public Health
Aim: To facilitate a timely understanding of the differences in the prevalence of gustatory disturbances (GD) in individuals infected with SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
7/20/21
Mahmud S, Hossain S, Muyeed A, et al. | Heliyon
Aim: To provide an overall scenario of the prevalence of depression, anxiety, stress, as well as insomnia and to inspect the changes in these prevalence over time by analyzing the existing evidence during this COVID-19 pandemic.
MENTAL HEALTH
7/19/21
Andrianto, Al-Farabi MJ, Nugraha RA, et al. | Microvasc Res
Aim: To assess biomarkers of endothelial cells in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/19/21
Rashedi S, Keykhaei M, Pazoki M, et al. | Nutr Clin Pract
Aim: To ascertain risk indicators of in-hospital mortality and severity as well as to provide a comprehensive systematic review and meta-analysis to investigate the prognostic significance of the prognostic nutrition index (PNI) as a predictor of adverse outcomes in hospitalized coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
7/19/21
Harder T, Koch J, Vygen-Bonnet S, et al. | Euro Surveill
Aim: To assess the extent to which COVID-19 vaccines are able to prevent symptomatic and asymptomatic infections to guide public health recommendations and develop strategies for fully vaccinated people.
UPDATED
INFECTION CONTROL
7/19/21
Chivese T, Musa OAH, Hindy G, et al. | Travel Med Infect Dis
Aim: To synthesize findings from systematic reviews and meta-analyses on the efficacy and safety of chloroquine (CQ) and hydroxychloroquine (HCQ) with or without Azithromycin for treating COVID-19.
CANDIDATE THERAPEUTICS
7/19/21
Saragih ID, Tonapa SI, Saragih IS, et al. | Int J Nurs Stud
Aim: To systematically identify the mental health problems among healthcare workers in various countries during the COVID-19 pandemic.
UPDATED
MENTAL HEALTH
7/19/21
Maddaloni E, D'Onofrio L, Siena A, et al. | Intern Emerg Med
Aim: To clarify the association of cardiovascular disease with Covid-19 outcomes.
CLINICAL CHARACTERISTICS
7/19/21
Luo C, Yang Y, Liu Y, et al.  | Am J Infect Control
Aim: To gain insight into willingness and its influencing factors to vaccinate against COVID-19 among health care workers (HCWs).
UPDATED
INFECTION CONTROL
7/19/21
Kim PH, Kim M, Suh CH, et al. | Korean J Radiol
Aim: To evaluate the incidence of radiologically demonstrated neurologic complications and detailed neuroimaging findings associated with COVID-19.
CLINICAL CHARACTERISTICS
7/19/21
van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, et al. | Fam Pract
Aim: To create an overview of the nature and frequency of persistent symptoms experienced by patients after mild COVID-19 infection.
CLINICAL CHARACTERISTICS
7/19/21
Alkofide H, Almohaizeie A, Almuhaini S, et al. | Int J Infect Dis
Aim: To systematically review the literature on the association between the combination of tocilizumab (TCZ) and systemic corticosteroid therapy (SCT) on outcomes of COVID-19 patients.
UPDATED
CANDIDATE THERAPEUTICS
7/17/21
John A, Eyles E, Webb RT, et al.  | F1000Research
Aim: To identify and appraise any newly published evidence from around the world that assesses the impact of the COVID-19 pandemic on suicide deaths, suicidal behaviours, self-harm and suicidal thoughts, or that assesses the effectiveness of strategies to reduce the risk of suicide deaths, suicidal behaviours, self-harm and suicidal thoughts, resulting from the COVID-19 pandemic.
UPDATED
MENTAL HEALTH
7/16/21
Iwamura APD, Tavares da Silva MR, Hümmelgen AL, et al.  | Rev Med Virol
Aim: To collate and critically appraise the literature relating to the inflammatory and immunological parameters of the SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/16/21
Demissie DB, Bitew ZW | SAGE Open Med
Aim: To examine the effects of coronavirus disease 2019 pandemic on the prevalence of anxiety, depression, stress, insomnia, and social dysfunction among pregnant and/or lactating women.
MENTAL HEALTH
7/16/21
Ranse J, Beckwith D, Khan A, et al. | Prehosp Disaster Med
Aim: To identify and analyze papers relating to novel respiratory viruses with pandemic potential and to inform MGE planning.
INFECTION CONTROL
7/16/21
Franceschi VB, Santos AS, Glaeser AB, et al. | Rev Med Virol
Aim: To evaluate the qualitative aspects of population-based seroprevalence surveys of COVID-19, including their reliability and biases.
UPDATED
7/16/21
Ling Y, Zhong J, Luo J, et al. | J Med Virol
Aim: To systematically evaluate the effectiveness and safety of the SARS-CoV-2 vaccines currently undergoing clinical trials.
INFECTION CONTROL
7/16/21
Agarwal L, Agarwal A, Advani S, et al. | BR J Radiol
Aim: To scope the existing literature on the abdominal imaging findings in COVID-19.
UPDATED
7/16/21
El-Qushayri AE, Ghozy S, Reda A, et al. | Rev Med Virol
Aim: To review the impact of PD on the prognosis of Covid-19 patients.
CLINICAL CHARACTERISTICS
7/15/21
 | EUnetHTA
Aim: To review the evidence on the use of anakinra for the treatment for COVID-19.
UPDATED
7/15/21
 | EUnetHTA
Aim: To review the evidence on the use of APN01 for the treatment for COVID-19.
UPDATED
7/15/21
 | EUnetHTA
Aim: To review the evidence on the use of aspirin for the treatment for COVID-19.
UPDATED
7/15/21
 | EUnetHTA
Aim: To review the evidence on the use of baricitinib for the treatment for COVID-19.
UPDATED
7/15/21
 | EUnetHTA
Aim: To review the evidence on the use of camostat for the treatment for COVID-19.
UPDATED
7/15/21
Jiang F, Xu N, Zhou Y, et al. | Phytother Res
Aim: To review the efficacy and safety of treating COVID-19 with combined traditional Chinese medicine (TCM) and conventional western medicine (CWM).
UPDATED
CANDIDATE THERAPEUTICS
7/15/21
Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, et al. | Crit Care Med
Aim: To describe the prevalence of coronavirus disease 2019-related sepsis.
UPDATED
CLINICAL CHARACTERISTICS
7/15/21
Pai N, Vella S | Aust N Z J Psychiatry
Aim: To perform an updated and timely rapid systematic review to identify, assess and summarise available peer-reviewed research on loneliness during the current COVID-19 pandemic.
MENTAL HEALTH
7/15/21
Aeen FB, Pakzad R, Rad MG, et al. | Sci Rep
Aim: To determine the effects of PP on respiratory parameters and outcomes.
UPDATED
CANDIDATE THERAPEUTICS
7/15/21
Saragih ID, Advani S, Saragih IS, et al. | Geriatr Nurs
Aim: To study the impacts of frailty on COVID-19 outcomes.
UPDATED
CLINICAL CHARACTERISTICS
7/15/21
 | EUnetHTA
Aim: To review the evidence on the use of ivermectin for the treatment for COVID-19.
UPDATED
7/15/21
Mir A, Farmanfarma KK, Salehiniya H, et al. | Monaldi Arch Chest Dis
Aim: To investigate laboratory and demographic findings among patients with COVID-19 worldwide.
CLINICAL CHARACTERISTICS
7/15/21
de Medeiros KS, da Silva LAS, de Araujo Macedo LT, et al. | Rev Assoc Med Bras
Aim: To study the clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection.
CLINICAL CHARACTERISTICS
7/15/21
Yetmar Z, Chesdachai S, Kashour T, et al. | Open Forum Infect Dis
Aim: To examine the association between prior statin use and outcomes of patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/15/21
Low JM, Low YW, Zhong Y, et al. | Arch Dis Child Fetal Neonatal Ed
Aim: To review the evidence on the production of SARS-CoV-2 antibodies in human milk of individuals who had COVID-19, and antibodies' ability to neutralise SARS-CoV-2 infectivity.
UPDATED
INFECTION CONTROL
7/14/21
Jenniskens K, Bootsma MCJ, Damen JAAG, et al. | BMJ Open
Aim: To systematically review evidence on effectiveness of contact tracing apps (CTAs) for SARS-CoV-2 on epidemiological and clinical outcomes.
INFECTION CONTROL
7/14/21
Yassin A, Ghzawi A, Al-Mistarehi AH, et al. | Future Sci OA
Aim: To describe the mortality difference between acute ischemic stroke (AIS) and non-AIS groups within COVID-19 patients.
CLINICAL CHARACTERISTICS
7/13/21
Pashazadeh Kan F, Raoofi S, et al. | J Affect Disord
Aim: To identify the individuals at higher risk of anxiety with a view to provide targeted mental health services during this outbreak.
UPDATED
MENTAL HEALTH
7/13/21
Nasa P, Juneja D, Jain R, et al. | Asian Cardiovasc Thorac Ann
Aim: To analyse the types of air leaks in COVID-19 and their outcomes.
CLINICAL CHARACTERISTICS
7/13/21
Wu X, Xu Y, Jin L, et al. | Front Med
Aim: To investigate the mortality of patients with COVID-19 in relation to preexisting asthma and other allergic diseases associated with changes in respiratory function.
CLINICAL CHARACTERISTICS
7/13/21
Zinellu A, Sotgia S, Carru C, et al. | Front Cardiovasc Med
Aim: To conduct a meta-regression of studies reporting plasma BNP or NT-proBNP concentrations in COVID-19 patients with different disease severity.
CLINICAL CHARACTERISTICS
7/13/21
Dadashi M, Khaleghnejad S, Abedi Elkhichi P, et al.  | Front Med
Aim: To systematically review the literature on COVID-19 co-infections with the influenza virus (type A and/or B).
CLINICAL CHARACTERISTICS
7/13/21
Viswanatha GL, Anjana Male CKVLSN, Shylaja H, et al. | Clin Exp Rheumatol
Aim: To evaluate the therapeutic benefits and safety of tocilizumab (TCZ) in treating severe coronavirus disease 2019 (COVID-19) and associated health complications.
UPDATED
CANDIDATE THERAPEUTICS
7/13/21
Akobeng AK, Grafton-Clarke C, Abdelgadir I, et al. | Frontline Gastroenterol
Aim: To summarise the published evidence on the gastrointestinal manifestations of COVID-19 in children and to determine the prevalence of gastrointestinal symptoms.
UPDATED
CLINICAL CHARACTERISTICS
7/13/21
Hariyanto TI, Lugito NPH, Yanto TA, et al. | Endocr Metab Immune Disord Drug Targets
Aim: To evaluate the possible association between insulin and the poor composite development of COVID-19.
CLINICAL CHARACTERISTICS
7/13/21
Tegegne GT, Kefale B, Engidaw MT, et al. | Front Public Health
Aim: To investigate the level of KAP and associated factors among HCPs about COVID-19. 
UPDATED
INFECTION CONTROL
7/13/21
Klopfenstein T, Gendrin V, Gerazime A, et al. | Infect Dis Ther
Aim: To conduct a subgroup meta-analysis between severe and non-severe COVID-19 treated by tocilizumab.
CANDIDATE THERAPEUTICS
7/13/21
Carr EJ, Kronbichler A, Graham-Brown M, et al. | Kidney Int Rep
Aim: To review and discuss the possible implications of the early vaccination data.
INFECTION CONTROL
7/13/21
Raeisi T, Mozaffari H, Sepehri N, et al. | Eat Weight Disord
Aim: To evaluate the global prevalence of obesity in COVID-19 patients and to investigate whether obesity is a risk factor for the COVID-19, COVID-19 severity, and its poor clinical outcomes including hospitalization, intensive care unit (ICU) admission, need for mechanical ventilation, and mortality.
CLINICAL CHARACTERISTICS
7/13/21
de Oliveira L, Carvalho J | Curr Sex Health Rep
Aim: To describe current findings on women's sexual health during this period.
MENTAL HEALTH
7/12/21
Pavlov I, He H, McNicholas B, et al. | Respir Care
Aim: To synthesize the available evidence on the efficacy of APP.
CANDIDATE THERAPEUTICS
7/12/21
Alimoradi Z, Gozal D, Tsang HWH, et al. | J Sleep Res
Aim: To answer the important question regarding prevalence of sleep problems during the COVID-19 outbreak period between genders. 
MENTAL HEALTH
7/12/21
Gupta T, Thakkar P, Kalra B, et al. | Rev Med Virol
Aim: To evaluate the role of hydroxychloroquine (HCQ) in the treatment of COVID-19 infection.
CANDIDATE THERAPEUTICS
7/12/21
Zein AFMZ, Sulistiyana CS, Raffaelo WM, et al. | Diabetes Metab Syndr
Aim: To investigate the effect of ivermectin on mortality in patients with COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
7/12/21
Ebenezer O, Jordaan MA, Ogunsakin RE, et al. | Hippokratia
Aim: To identify active compounds with possibilities of combating COVID-19 infection.
CANDIDATE THERAPEUTICS
7/12/21
Shi C, Wang L, Ye J, et al. | BMC Infect Dis
Aim: To assess the potential predictors of mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/12/21
Savage HR, Santos VS, Edwards T, et al. | PLoS Negl Trop Dis
Aim: To review the evidence on the proportion of individuals with SARS-CoV-2 neutralising antibodies after infection and how this proportion varies with selected covariates.
CLINICAL CHARACTERISTICS
7/12/21
Kollias A, Kyriakoulis KG, Kyriakoulis IG, et al. | Atherosclerosis
Aim: To review the evidence regarding statin treatment and COVID-19 related mortality.
CLINICAL CHARACTERISTICS
7/12/21
Mansory E, Srigunapalan S, Lazo-Langner A | TH Open
Aim: To evaluate the epidemiology of VTE in hospitalized intensive care unit (ICU) and non-ICU patients.
UPDATED
CLINICAL CHARACTERISTICS
7/12/21
Truong J, Bakshi S, Wasim A, et al. | Health Promot Int
Aim: To examine the factors that promote vaccine hesitancy or acceptance during pandemics, major epidemics and global outbreaks.
INFECTION CONTROL
7/12/21
Wilson J, Garson G, Fitzgerald S, et al. | J Hosp Infect
Aim: To evaluate the evidence for aerosol production and transmission of respiratory infection associated with procedures that involve airway suctioning or induce coughing/sneezing.
INFECTION CONTROL
7/9/21
Schwartzberg L, Advani S, Clancy DC, et al. | Skin Health Dis
Aim: To summarize cutaneous manifestations associated with COVID?19.
UPDATED
CLINICAL CHARACTERISTICS
7/9/21
Pavlov I, He H, McNicholas B, et al. | Respir Care
Aim: To synthesize the available evidence on the efficacy of APP.
UPDATED
CANDIDATE THERAPEUTICS
7/9/21
Lin YN, Liu ZR, Li SQ, et al. | Nat Sci Sleep
Aim: To summarize the current evidence for the impacts of COVID-19 on sleep in patients with COVID-19, healthcare workers (HWs), and the general population.
MENTAL HEALTH
7/9/21
Sharma GD, Tiwari AK, Jain M, et al. | Renew Sustain Energy Rev
Aim: To synthesize the evidence regarding the environmental concerns of COVID-19.
INFECTION CONTROL
7/9/21
Barssoum K, Victor V, Salem A, et al. | Echocardiography
Aim: To provide an overview of current findings and recommendations in cardiovascular imaging in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/9/21
Rathore SS, Rojas GA, Sondhi M, et al. | Int J Clin Pract
Aim: To compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19.
CLINICAL CHARACTERISTICS
7/9/21
Abou-Setta AM, Lam O, Kasireddy V, et al. | SPOR Evidence Alliance
Aim: To review the evidence on the rate of pregnant persons admitted to the ICU/developing severe COVID outcomes.
7/8/21
Ramlah R | Ann Hepatobiliary Pancreat Surg
Aim: To determine the relationship between COVID-19 and acute pancreatitis.
CLINICAL CHARACTERISTICS
7/8/21
Najt P, Richards HL, Fortune D | Brain Behav Immun Health
Aim: To synthesise the potential evidence of the brain correlates of SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Gaythorpe K, Bhatia S, Mangal T, et al. | Sci Rep
Aim: To review the evidence on the susceptibility of children to SARS-CoV-2 infection, the severity and clinical outcomes in children with SARS-CoV-2 infection, and the transmissibility of SARS-CoV-2 by children.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Sharma A, Ghosh D, Divekar N, et al. | Int Soc Sci J
Aim: To compare and assess the socio?economic implications of the 1918 influenza pandemic and the COVID?19 pandemic in India. 
7/8/21
Ulloque-Badaracco JR, Salas-Tello WI, Al-Kassab-Cordova A, et al. | Int J Clin Pract
Aim: To evaluate the prognostic value of the NLR in patients diagnosed with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Chisale MRO, Ramazanu S, Mwale SE, et al. | Rev Med Virol
Aim: To estimate the seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in residents of African countries and explore its associated factors.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Egunsola O, Mastikhina L, Dowsett L, et al. | SPOR
Aim: To identify comparative observational studies and randomized controlled trials (RCTs) evaluating the effectiveness or efficacy of COVID-19 vaccination in reducing infection transmission, asymptomatic viral carriage and other proxies of possible transmission, such as cycle threshold (Ct) values and viral load.
UPDATED
7/7/21
Soltani S, Faramarzi S, Zandi M, et al. | New Microbes New Infect
Aim: To systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles.
CLINICAL CHARACTERISTICS
7/7/21
Al-Amer R, Maneze D, Everett B, et al. | J Clin Nurs
Aim: To synthesise evidence regarding vaccination intention, identify factors contributing to vaccine hesitancy among healthcare professionals and the general populations globally.
UPDATED
INFECTION CONTROL
7/7/21
Malin JJ, Spinner CD, Janssens U, et al. | Infection
Aim: To provide rapid evidence based recommendations on the role of drug interventions in the treatment of hospitalized patients with COVID-19.
CANDIDATE THERAPEUTICS
7/7/21
Chen M, Yuan Y, Zhou Y, et al. | Infect Dis Poverty
Aim: To determine the safety of existing COVID-19 vaccine candidates from randomized controlled trials (RCTs).
INFECTION CONTROL
7/7/21
Pardhan S, Wood S, Vaughan M, et al. | Front Med
Aim: To examine the adjusted risk of COVID-19 related hospitalsation, intensive care unit (ICU) admission, and mortality in patients with vs. without asthma or COPD.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Kremer D, Pieters TT, Verhaar MC, et al. | Am J Transplant
Aim: To assess all current evidence to provide an updated and robust insight in the clinical course and outcome of COVID-19 in KTR.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Lassi ZS, Ana A, Das JK, et al. | J Glob Health
Aim: To determine the clinical presentation, risk factors, and pregnancy and perinatal outcomes in pregnant women with confirmed COVID-19 and identify if these are different based on COVID-19 severity.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Islam MN, Islam AKMN | IEEE Access
Aim: To synthesize the digital interventions initiatives to fight against COVID-19 in Bangladesh and compare with other countries.
INFECTION CONTROL
7/6/21
Sadhasivam S, Arora RK, Rekapalli R, et al. | Asian J Neurosurg
Aim: To systematically review the impact of the current pandemic on neurosurgical practice and to find out a safe way of practicing neurosurgery amid the highly infectious patients with COVID-19.
INFECTION CONTROL
7/6/21
Correia de Sá T, Soares C, Rocha M | World J Gastrointest Surg
Aim: To review and to explore the relationship between SARS-CoV-2 infection and AP, and to provide an overview of the existing literature on possible mechanisms of SARS-CoV-2-induced pancreatic lesion.
CLINICAL CHARACTERISTICS
7/6/21
Lee AC, Tse Li W, Apostol L, et al. | Comput Struct Biotechnol J
Aim: To examine the extent that age influences correlation results and by analyzing patients with severe COVID-19 and patients who died from COVID-19 separately.
CLINICAL CHARACTERISTICS
7/6/21
Gianfredi V, Pennisi F, Lume A, et al. | Vaccines
Aim: To collect and review previous experiences on mass vaccination centers.
INFECTION CONTROL
7/6/21
Alhumaid S, Al Mutair A, Al Alawi Z, et al. | Pathogens
Aim: To calculate the prevalence of coinfections with bacteria, fungi, and respiratory viruses in patients with SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/6/21
Franchini M, Prefumo F, Grisolia G, et al. | Viruses
Aim: To systematically examine the current evidence on the clinical use of convalescent plasma during pregnancy.
UPDATED
CANDIDATE THERAPEUTICS
7/6/21
Omidi F, Hajikhani B, Kazemi SN, et al. | Front Cardiovasc Med
Aim: To systematically review the current published literature to evaluate clinical and paraclinical characteristics of CMPs in patients infected with SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/6/21
Dube R, Kar SS | BMJ Paediatr Open
Aim: To determine the effects of confirmed cases of COVID-19 in pregnant women from the foetal perspective by estimation of mother to child transmission, perinatal outcome and possible teratogenicity.
CLINICAL CHARACTERISTICS
7/6/21
Eljaaly K, Malibary H, Alsulami S, et al. | Pathogens
Aim: To describe the characteristics of clinical trials that focused on COVID-19 patients with cytokine release syndrome (CRS) and the variability in CRS definitions.
CLINICAL CHARACTERISTICS
7/6/21
Fernández Villalobos NV, Ott JJ, Klett-Tammen CJ, et al. | Syst Rev
Aim: To review the evidence on the relation between individual co-morbidities and disease severity (e.g., as measured by ICU admission) and further identify potential interactions with age.
CLINICAL CHARACTERISTICS
7/6/21
Dadras O, Alinaghi SAS, Karimi A, et al. | Eur J Med Res
Aim: To investigate the incidence of seasonal influenza and other respiratory viral infections during and after the introduction of COVID-19 lockout.
INFECTION CONTROL
7/6/21
Chan VW, Tan WS, Asif A, et al. | Cancers
Aim: To review the evidence surrounding expectant management, delay radical prostatectomy (RP), and neoadjuvant hormone therapy (NHT) compared to immediate RP.
INFECTION CONTROL
7/6/21
Sosa JP, Ferreira Caceres MM, Ross Comptis J, et al. | Infect Chemother
Aim: To review the efficacy and safety of Interferon Beta in patients who have a confirmed COVID-19 diagnosis.
CANDIDATE THERAPEUTICS
7/6/21
Cheng H, Peng Z, Luo W, et al. | Vaccines
Aim: To summarize the clinical trials of COVID-19 vaccines that are currently widely vaccinated to compare their efficacy and safety.
INFECTION CONTROL
7/6/21
Hernandez AV, Phan MT, Rocco J, et al. | J Clin Med
Aim: To review the efficacy and safety of hydroxychloroquine as treatment for hospitalized COVID-19.
CANDIDATE THERAPEUTICS
7/6/21
Wibowo A, Pranata R, Lim MA, et al. | Int J Infect Dis
Aim: To compare the level of von Willebrand Factor (vWF) antigen in patients with poor outcome compared to those without. 
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Townsend R, Chmielewska B, Barratt I, et al. | EClinicalMedicine
Aim: To evaluate reported changes in maternity care provision and uptake during the global COVID-19 pandemic.
INFECTION CONTROL
7/6/21
Li M, Luo Y, Watson R, et al. | Postgrad Med J
Aim: To synthesise evidence on HCWs' attitudes towards COVID-19 vaccination and analyse associated factors to provide information for vaccine policy development and practice.
INFECTION CONTROL
7/6/21
Hernandez AV, Ingemi J 3rd, Sherman M, et al. | J Clin Med
Aim: To assess all available controlled studies evaluating the prophylactic use of hydroxychloroquine to prevent COVID-19 infection to identify its benefits and adverse events.
INFECTION CONTROL
7/6/21
Lee SA, Park R, Yang JH, et al. | Sci Rep
Aim: To investigate the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patients through meta-analysis.
CLINICAL CHARACTERISTICS
7/6/21
Serrano-Ripoll MJ, Zamanillo-Campos R, Castro A, et al. | Actas Esp Psiquiatr
Aim: To examine the impact of the current health pandemic produced by COVID-19 on insomnia and sleep quality of health professionals, and to identify risk factors associated with insomnia.
UPDATED
MENTAL HEALTH
7/6/21
Singh AK, Singh R, Joshi SR, et al. | Diabetes Metab Syndr
Aim: To find out the patient's characteristics having mucormycosis and COVID-19.
CLINICAL CHARACTERISTICS
7/6/21
Donkor A, Atuwo-Ampoh VD, Opie C, et al. | Rep Pract Oncol Radiother
Aim: To identify strategies adopted by radiotherapy centres in LMICs to mitigate the effects of COVID-19.
INFECTION CONTROL
7/6/21
Moya-Salazar J, Cañari B, Gomez-Saenz L, et al. | F1000Research
Aim: To determine the impact of stickers and memes as tools to face the COVID-19 pandemic.
INFECTION CONTROL
7/6/21
de Matos BTL, Buchaim DV, Pomini KT, et al. | Life
Aim: To analyze the use of PBMT as a possible new approach as a complementary therapy in the treatment of patients affected by COVID-19.
CANDIDATE THERAPEUTICS
7/6/21
Zhang H, Li W, Li H, et al. | Gen Psychiatr
Aim: To outline the prevalence and dynamic changing features of medical workers’ psychological issues and to review the related national policies during the COVID-19 pandemic in China.
MENTAL HEALTH
7/6/21
Romiti GF, Corica B, Lip GYH, et al. | J Clin Med
Aim: To investigate the epidemiology of AF in COVID-19 patients and its impact on all-cause mortality.
UPDATED
CANDIDATE THERAPEUTICS
7/6/21
Hao Q, Wang D, Xie M, et al. | Front Psychiatry
Aim: To review the evidence on the prevalence of mental health problems and risk factors among HCWs during the COVID-19 pandemic to identify at-risk HCWs and provide timely assistance and intervention.
UPDATED
MENTAL HEALTH
7/6/21
Rodríguez-Fernández P, González-Santos J, Santamaría-Peláez M, et al. | Int J Environ Res Public Health
Aim: To identify the best available scientific evidence on the impact that home confinement and social distancing, derived from the SARS-CoV-2 pandemic, have had on the mental health of the general population in terms of depression, stress and anxiety. 
MENTAL HEALTH
7/6/21
Bertuzzi V, Semonella M, Bruno D, et al. | Int J Environ Res Public Health
Aim: To review the evidence on the content and efficacy of the psychological support interventions in increasing mental health among healthcare providers and informal caregivers during the COVID-19 pandemic.
UPDATED
MENTAL HEALTH
7/6/21
Wang YY, Huang Q, Shen Q, et al. | Front Med
Aim: To assess the quality of relevant COVID-19 clinical practice guidelines (CPGs) and to compare the similarities and differences between recommendations.
7/6/21
Mude W, Oguoma VM, Nyanhanda T, et al. | J Glob Health
Aim: To review the evidence on disparities in prevalence, hospitalisation, and deaths from COVID-19 by racial minority populations.
CLINICAL CHARACTERISTICS
7/6/21
Siavashpour Z, Goharpey N, Mobasheri M | Crit Rev Oncol Hematol
Aim: To provide an overview of the presented guidelines of radiotherapy national/international organizations or individual departments' consensus during this pandemic regarding patient care. 
INFECTION CONTROL
7/6/21
Ali DM, Zake LG, El Kady NK, et al. | Interdiscip Perspect Infect Dis
Aim: To carry out a systematic review and meta-analysis to find out the role of chest CT scan versus RT-PCR for precise diagnosis of COVID-19 infection.
DIAGNOSTICS
7/6/21
Schubert M, Ludwig J, Freiberg A, et al. | Int J Environ Res Public Health
Aim: To provide a comprehensive overview of COVID-19-related stigmatization across occupational classes. 
MENTAL HEALTH
7/6/21
Foret T, Dufrost V, du Mont LS, et al. | Curr Rheumatol Rep
Aim: To analyze the frequency of aPL in COVID-19 patients in different settings and to evaluate their persistence over time and to analyze the role of aPL during the infection in particular their participation in thrombotic events.
CLINICAL CHARACTERISTICS
7/6/21
Romero Starke K, Mauer R, Karskens E, et al. | Int J Environ Res Public Health
Aim: To collect evidence on the impact of temperature and humidity on COVID-19 mortality. 
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Gupta A, Kavanagh A, Disney G, et al. | Int J Environ Res Public Health
Aim: To collate evidence on the risk of infection for people with disability during infectious disease outbreaks and/or pandemics and government responses and pandemic plans for people with disability. 
INFECTION CONTROL
7/6/21
Beukes E, Ulep AJ, Eubank T, et al. | J Clin Med
Aim: To systematically review what has been published regarding tinnitus during the coronavirus disease 2019 (COVID-19) pandemic up to March 2021.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Chigwedere OC, Sadath A, Kabir Z, et al. | Int J Environ Res Public Health
Aim: To examine the impact of epidemics and pandemics on the mental health of HCWs.
UPDATED
MENTAL HEALTH
7/6/21
Akbar MR, Pranata R, Wibowo A, et al. | Front Med
Aim: To assess the prognostic value of hyponatremia in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Somagutta MKR, Lourdes Pormento MK, Hamid P, et al. | Infect Chemother
Aim: To assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
7/6/21
Kollikonda S, Chavan M, Cao C, et al. | J Neonatal Perinatal Med
Aim: To examine the success of different practices in preventing viral transmission between SARS-CoV-2 positive mothers and their infants.
INFECTION CONTROL
7/6/21
Rawat D, Roy A, Maitra S, et al. | Diabetes Metab Syndr
Aim: To investigate the role of supplementation of Vitamin D among COVID-19 patients on their disease outcomes.
CANDIDATE THERAPEUTICS
7/6/21
Noh EB, Nam HK, Lee H | Infect Chemother
Aim: To organize the vaccine priorities that are being emphasized at this time.
INFECTION CONTROL
7/2/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the best practice management of a COVID-19 neonate.
7/2/21
Zein AFMZ, Sulistiyana CS, Khasanah U, et al. | Postgrad Med J
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Melo AKG, Milby KM, Caparroz ALMA, et al. | PLoS One
Aim: To describe the laboratory parameters and biomarkers of the cytokine storm syndrome associated with severe and fatal COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Abeldaño Zuñiga RA, González-Villoria RAM, Elizondo MV, et al. | Ther Adv Respir Dis
Aim: To determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients with diagnosis of COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
7/1/21
Ciapponi A, Bardach A, Comande D, et al.  | PLoS One
Aim: To summarize the best evidence regarding the effect of COVID-19 on maternal and child health.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Taylor EH, Marson EJ, Elhadi M, et al. | Anaesthesia
Aim: To determine factors associated with mortality among adults with COVID-19 admitted to intensive care.
CLINICAL CHARACTERISTICS
7/1/21
Kula B, Clancy CJ, Nguyen MG, et al. | Lancet Microbe
Aim: To establish the prevalence of autopsy-proven tissue-invasive IMD and analyse individual-level data to assess potential risk factors.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Chung S, Marlow S, Tobias N, et al. | BMJ Open
Aim: To systematically learn lessons from the experiences of countries implementing find, test, trace, isolate, support (FTTIS) in the first wave of the COVID-19 pandemic.
INFECTION CONTROL
7/1/21
Veazie S, O'Neil M, LaFavor B, et al.  | VA Evidence Synthesis Program
Aim: To compare the prevalence of mental health disorders among adults who have been hospitalized for COVID-19 to relevant comparison groups, assess whether the prevalence of mental health disorders varies by patient and disease characteristics, and ascertain mental health care utilization and resource needs for adults following hospitalization for COVID-19.
UPDATED
VA ESP
MENTAL HEALTH
7/1/21
Sitek AN, Ade JM, Chiarella SE, et al. | Allergy Asthma Proc
Aim: To review the evidence on whether asthma is a risk factor associated with worse outcomes among patients with COVID-19.
CLINICAL CHARACTERISTICS
7/1/21
Vancini RL, Andrade MS, Viana RB, et al. | Sports Med Health Sci
Aim: To conduct a review of randomized controlled trial articles for one-year of information production focusing on the year 2020 concerning COVID-19 and PA, physical exercise, physical training, sport, and physical fitness.
MENTAL HEALTH
7/1/21
Gupta T, Kannan S, Kalra B, et al. | Transfus Med
Aim: To evaluate the safety and efficacy of convalescent plasma therapy in COVID-19.
CANDIDATE THERAPEUTICS
7/1/21
Wake AD | Risk Manag Healthc Policy
Aim: To assess the level of willingness to receive COVID-19 vaccine and its associated factors.
INFECTION CONTROL
6/30/21
O'Sullivan L, Killeen RP, Doran P, et al. | BMC Med Ethics
Aim: To determine whether COVID-19 human research publications report compliance with ethical safeguards.
6/30/21
Arian M, Valinejadi A, Vakilian F | Iran J Public Health
Aim: To report the findings of the first Electrocardiography (ECG), before therapy initiation and receiving medication in COVID-19 patients, and to compare them with the ECG findings of healthy men.
CLINICAL CHARACTERISTICS
6/30/21
Chua EX, Zahir SMISM, Ng KT, et al. | J Clin Anesth
Aim: To investigate the effect of prone position on partial pressure of arterial oxygen/fraction of inspired oxygen (PaO2/FiO2) ratio.
UPDATED
CANDIDATE THERAPEUTICS
6/30/21
Sharma M, Aggarwal S, Madaan P, et al. | Sleep Med
Aim: To study the prevalence and pattern of sleep disturbances in children and adolescents during the COVID-19 pandemic.
UPDATED
MENTAL HEALTH
6/30/21
Sharma M, Aggarwal S, Madaan P, et al. | Sleep Med
Aim: To study the prevalence and pattern of sleep disturbances in children and adolescents during the COVID-19 pandemic.
UPDATED
MENTAL HEALTH
6/30/21
Crafa A, Cannarella R, Condorelli RA, et al. | EClinicalMedicine
Aim: To assess whether hypovitaminosis D is a risk factor for developing SARS-CoV-2 infection and whether it affects the worsening of the clinical course of COVID-19.
CLINICAL CHARACTERISTICS
6/30/21
Roman YM, Burela PA, Pasupuleti V, et al. | Clin Infect Dis
Aim: To assess benefits and harms of the use of ivermectin (IVM) in COVID-19 patients.
CANDIDATE THERAPEUTICS
6/29/21
Iqbal U, Anwar H, Siddiqui Hux, et al. | Clin Endosc
Aim: To evaluate the outcomes of COVID-19 patients with signs and symptoms of acute gastrointestinal bleeding (GIB).
CLINICAL CHARACTERISTICS
6/29/21
Arian M, Valinejadi A, Vakilian F | Iran J Public Health
Aim: To report the findings of the first Electrocardiography (ECG), before therapy initiation and receiving medication in COVID-19 patients, and to compare them with the ECG findings of healthy men.
CLINICAL CHARACTERISTICS
6/29/21
Mohd-Said S, Mohd-Dom TN, Suhaimi N, et al. | Front Med
Aim: To evaluate the effectiveness of pre-procedural rinsing when preforming periodontal prophylaxis in reducing aerosol contamination in the dental setting.
INFECTION CONTROL
6/29/21
Crafa A, Cannarella R, Condorelli RA, et al. | EClinicalMedicine
Aim: To assess whether hypovitaminosis D is a risk factor for developing SARS-CoV-2 infection and whether it affects the worsening of the clinical course of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/29/21
Jin H, Chen Y, Fu Q, et al. | Work
Aim: To obtain comprehensive and detailed information on occupational risk factors of infectious diseases for HWs in different dimensions and to propose control strategies for three risk dimensions to protect HWs who are at high risk of infection during the pandemic.
INFECTION CONTROL
6/29/21
Tang X, Musa SS, Zhao S, et al. | Front Public Health
Aim: To provide recommendations to help to prevent further spread of SARS-CoV-2.
INFECTION CONTROL
6/29/21
Vindrola-Padros C, Singh KE, Sidhu MS, et al. | EClinicalMedicine
Aim: To analyse the implementation and impact of remote home monitoring models (virtual wards) during COVID-19, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt.
UPDATED
INFECTION CONTROL
6/29/21
Luo F, Ghanei Gheshlagh R, Dalvand S, et al. | Front Psychol
Aim: To estimate the pooled mean of fear of COVID-19 around the world.
MENTAL HEALTH
6/28/21
Ramadan MS, Bertolino L, Zampino R, et al. | Clin Microbiol Infect
Aim: To assess the range of cardiac sequelae after COVID-19 recovery.
CLINICAL CHARACTERISTICS
6/28/21
Song WL, Zou N, Guan WH, et al. | World J Pediatr
Aim: To assess clinical profiles of COVID-19 in family clusters with children.
CLINICAL CHARACTERISTICS
6/28/21
Kulkarni MS, Kakodkar P, Nesari TM, et al. | J Ayurveda Integr Med
Aim: To summarise the evidence from different systematic reviews of distinct yoga interventions used to improve mental health and recommend yoga practices for the same. 
UPDATED
MENTAL HEALTH
6/28/21
Teles Abrao Trad A, Ibirogba ER, Elrefaei A, et al. | Hypertens Pregnancy
Aim: To add to the growing evidence on SARS-CoV-2 infection during pregnancy, so as to better inform clinical decision making and optimize patient outcomes.
CLINICAL CHARACTERISTICS
6/28/21
Mark EG, McAleese S, Golden WC, et al. | Pediatr Infect Dis J
Aim: To review outcomes in pregnant women with COVID-19 and neonates with perinatal exposure.
CLINICAL CHARACTERISTICS
6/28/21
Figueiro-Filho EA, Yudin M, Farine D, et al. | J Perinat Med
Aim: To identify the most significant studies reporting on COVID-19 during pregnancy and to provide an overview of SARS-CoV-2 infection in pregnant women and perinatal outcomes.
CLINICAL CHARACTERISTICS
6/28/21
Lazarus G, Budiman RA, Rinaldi I, et al. | Cancer Immunol Immunother
Aim: To investigate the effects of ICI treatment on COVID-19 prognosis, including mortality, severity, and any other prognosis-related outcomes.
UPDATED
CANDIDATE THERAPEUTICS
6/28/21
Prakash A, Kaur S, Kaur C, et al. | Indian J Pharmacol
Aim: To analyze the effect of inhaled nitric oxide (iNO) in the treatment of severe COVID-19 and to compare it to standard of care (SOC), antiviral medications, and other medicines.
CANDIDATE THERAPEUTICS
6/28/21
Singh S, Khera D, Chugh A, et al. | BMJ Open
Aim: To evaluate remdesivir, an RNA polymerase inhibitor, for effectiveness in adults with COVID-19.
CANDIDATE THERAPEUTICS
6/28/21
Silva CRACD, Oliveira LV, Lopes LP, et al. | Rev Assoc Med Bras
Aim: To review the immunological aspects of the 2019 coronavirus disease (COVID-19) in pregnancy.
CLINICAL CHARACTERISTICS
6/28/21
Kim CNH, Hutcheon J, van Schalkwyk J, et al. | Am J Obstet Gynecol
Aim: To estimate the CFR of pregnant women infected with SARS-CoV-2 admitted to the intensive care unit (ICU). 
CLINICAL CHARACTERISTICS
6/28/21
Irani M, Pakfetrat A, Mask MK, et al. | J Educ Health Promot
Aim: To evaluate the association of COVID-19 and perinatal outcomes in pregnant women.
CLINICAL CHARACTERISTICS
6/28/21
Ma L, Mazidi M, Li K, et al. | J Affect Disord
Aim: To examine the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender.
MENTAL HEALTH
6/28/21
Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, et al. | Eur J Intern Med
Aim: To analyze the prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized patients recovered from COVID-19 .
CLINICAL CHARACTERISTICS
6/28/21
Bellou V, Tzoulaki I, van Smeden M, et al. | Eur Respir J
Aim: To present a state-of-the-art systematic review and meta-analysis on the prognostic factors for adverse outcomes in COVID-19 patients.
CLINICAL CHARACTERISTICS
6/28/21
Panahi L, Amiri M, Pouy S, et al. | Arch Acad Emerg Med
Aim: To review the published evidence on the possibility of vertical transmission of the virus from mother to fetus.
INFECTION CONTROL
6/28/21
Cunning C, Hodes M | Clin Child Psychol Psychiatry
Aim: To review the literature available and assess the effect of the COVID-19 pandemic on OCD and obsessive–compulsive symptoms in young people.
MENTAL HEALTH
6/28/21
Chow R, Im J, Chiu N, et al. | PLoS One
Aim: To conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage. 
UPDATED
CANDIDATE THERAPEUTICS
6/28/21
Wang Q, Yang L, Jin H, et al. | Prev Med
Aim: To estimate the coronavirus disease 2019 (COVID-19) vaccine acceptance rate and identify predictors associated with acceptance. 
INFECTION CONTROL
6/28/21
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on parents' considerations for vaccine uptake for children and adolescents.
6/25/21
Drury J, Mao G, John A, et al. | BMC Public Health
Aim: To describe public attitudes towards certification, and its possible impact on uptake of testing and vaccination, protective behaviours, and crime.
UPDATED
INFECTION CONTROL
6/25/21
Richards H, Robins-Browne K, O'Brien T, et al. | Emerg Med J
Aim: To review the evidence relating to PP in the non-intubated patient with type 1 respiratory failure secondary to COVID-19 and other causes.
CANDIDATE THERAPEUTICS
6/25/21
Ren X, Wang X, Ge Z, et al. | Int J Immunopathol Pharmacol
Aim: To examine immune function status-related manifestations and laboratory indicators of COVID-19 patients with recurrent virus PCR positivity.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Nawangsih EN, Kusmala YY, Rakhmat II, et al. | Int Immunopharmacol
Aim: To evaluate the effect of colchicine administration on mortality in patients with COVID-19 and factors affecting the association.
UPDATED
CANDIDATE THERAPEUTICS
6/25/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of face masks at preventing COVID-19 transmission when the wearer has facial hair.
6/25/21
Bobrovitz N, Arora R, Cao C, et al.  | PLoS ONE
Aim: To synthesize seroprevalence data to better estimate the burden of SARS-CoV-2 infection, identify high-risk groups, and inform public health decision making.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Zinellu A, Mangoni A | Front Immunol
Aim: To investigate possible differences in the serum concentrations of two routinely measured complement components, C3 and C4, in COVID-19 patients with different severity and survival status.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
 | SPOR
Aim: To identify scientific evidence on surveillance and testing approaches to monitor the presence of the virus in a vaccinated population and determine how these influence testing strategies.
6/25/21
Mendez-Brito A, El Bcheraoui C, Pozo-Martin F | J Infect
Aim: To evaluate which non-pharmaceutical interventions (NPIs) have been more and less effective in controlling the COVID-19 pandemic.
CANDIDATE THERAPEUTICS
6/25/21
Yamamoto S, Saito M, Tamura A, et al. | PLoS One
Aim: To evaluate existing evidence on the association between the microbiome and COVID-19 in humans and summarize this data in the pandemic era.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Pal R, Banerjee M, Bhadada SK, et al. | J Endocrinol Invest
Aim: To provide a precise summary and collate the hitherto available clinical evidence on the effect of vitamin D supplementation on clinical outcomes in COVID-19 patients.
UPDATED
CANDIDATE THERAPEUTICS
6/25/21
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the effectiveness, immunogenicity, and safety of COVID-19 vaccines in persons who have had a prior, confirmed COVID-19 infection.
6/24/21
Wang Z, Joshi A, Leopold K, et al. | Clin Endocrinol
Aim: To evaluate the association between vitamin D deficiency and severity of COVID-19 infection.
CLINICAL CHARACTERISTICS
6/24/21
Samidoust P, Nikoupour H, Hemmati H, et al. | Ethiop J Health Sci
Aim: To explore available information on clinical presentations, laboratory finding and outcomes of SARS-COV-2 in liver transplant patients.
CLINICAL CHARACTERISTICS
6/24/21
Diaz-Arocutipa C, Carvallo-Castaneda D, Luis-Ybanez O, et al. | Clin Transplant
Aim: To summarize the clinical features, treatment, and outcomes of heart transplant recipients with COVID-19. 
CLINICAL CHARACTERISTICS
6/24/21
Gajbhiye RK, Sawant MS, Kuppusamy P, et al. | Int J Gynaecol Obstet
Aim: To compare clinical perinatal outcomes of women with COVID-19 from high-income countries (HICs) and low- to middle-income countries (LMICs).
CLINICAL CHARACTERISTICS
6/24/21
Murchu EO, Spillane S, Byrne P, et al. | Ann Pharmacother
Aim: To conduct a systematic review on the effectiveness and safety of pharmacological and nonpharmacological interventions, in the ambulatory setting, aimed at preventing severe disease in patients with COVID-19.
CANDIDATE THERAPEUTICS
6/24/21
Zapata-Ospina JP, Patino-Lugo DF, Velez CM, et al. | Rev Columb Psiquiatr
Aim: To review the evidence on the actions around promotion and prevention, mental symptoms care, and pedagogical adaptations that can be developed in order to improve the mental health of college and university students.
MENTAL HEALTH
6/24/21
Brurberg KG, Himmels JPW | Norwegian Institute of Public Health
Aim: To review the evidence on the risk of COVID-19 infection among people with immigrant backgrounds.
6/23/21
Zhuang J, Dai X, Jin Z, et al. | Complement Ther Med
Aim: To evaluate the clinical efficacy of LQ on the treatment of COVID-19.
CANDIDATE THERAPEUTICS
6/23/21
Gold N, Hu X, Denford S, et al. | BMC Public Health
Aim: To evaluate the evidence for digital interventions to improve hygiene practices within the community.
INFECTION CONTROL
6/23/21
Pinzon RT, Wijaya VO, Buana RB | J Infect Public Health
Aim: To synthesize the available evidence on the potential therapeutic effect of IL-6 inhibitor agents for the treatment of COVID-19.
CANDIDATE THERAPEUTICS
6/23/21
Tripathy SK, Varghese P, Panigrahi S, et al. | Chin J Traumatol
Aim: To evaluate the 30-day mortality and complications in COVID-19 + and COVID-19 ? patients with hip fractures.
UPDATED
CLINICAL CHARACTERISTICS
6/23/21
da Silva FCT, Neto MLR | J Psychiatr Res
Aim: To understand the impact that COVID-19 is having on the front-line clinical team in the ICU environment.
MENTAL HEALTH
6/23/21
Greenhawt M, Abrams EM, Shaker M, et al. | J Allergy Clin Immunol Pract
Aim: To systematically develop recommendations regarding SARS-CoV-2 vaccine immediate allergic reactions.
INFECTION CONTROL
6/23/21
Dautzenberg B, Levi A, Adler M, et al. | Respir Med Res
Aim: To conduct a systematic analysis of the nicotine doses used, the duration of use, the progressive increase or decrease of the doses, the side-effects leading, or not, to an interruption of the treatment, and the risk of developing a nicotine addiction in non-smokers.
CLINICAL CHARACTERISTICS
6/22/21
 | Health Information and Quality Authority
Aim: To identify the risk of COVID-19 re-infection over time.
6/22/21
Manca R, De Marco M, Ince PG, et al. | Front Aging Neurosci
Aim: To summarize the literature on neuroimaging and neuropathological findings in older over-60 patients with COVID-19 following a cognitive neuroscientific perspective, to clarify the most vulnerable brain areas and speculate on the possible cognitive consequences.
CLINICAL CHARACTERISTICS
6/22/21
Kumar A, Haider Y, Passey J, et al. | Bull Emerg Trauma
Aim: To analyze the factors associated with mortality in fracture patients with concomitant COVID-19 infection based on the available published data.
CLINICAL CHARACTERISTICS
6/22/21
Hintermeier M, Gencer H, Kajikhina K, et al. | J Migr Health
Aim: To synthesise the evidence on risk of infection and transmission among migrants, refugees, asylum seekers and internally displaced populations, and the effect of lockdown measures on these populations.
INFECTION CONTROL
6/22/21
Vijenthira A, Gong I, Betschel SD, et al. | Blood Adv
Aim: To perform a systematic review of the literature on vaccine responsiveness in patients who have received anti-CD20 therapy. 
INFECTION CONTROL
6/22/21
Beiter K, Hayden E, Phillippi S, et al. | Am J Surg
Aim: To examine trends in hospital reported violent trauma associated with the COVID-19 pandemic.
MENTAL HEALTH
6/21/21
Locquet M, Diep AN, Beaudart C, et al. | Arch Public Health
Aim: To identify, compare, and evaluate performances of prediction models for the diagnosis of COVID-19 in adult patients in a health care setting.
UPDATED
DIAGNOSTICS
6/21/21
Lewis A, Frontera J, Placantonakis DG, et al. | Clin Neurol Neurosurg
Aim: To review the literature on cerebrospinal fluid (CSF) testing in patients with altered olfactory/gustatory function due to COVID-19 for evidence of viral neuroinvasion.
CLINICAL CHARACTERISTICS
6/21/21
Amdal CD, Pe M, Falk RS, et al. | Qual Life Res
Aim: To identify all relevant health-related quality of life (HRQoL) issues associated with COVID-19.
CLINICAL CHARACTERISTICS
6/21/21
Prakash A, Singh H, Sarma P, et al.  | Sci Rep
Aim: To discuss the prevalence of neurological involvement of the 2019-nCoV patients and assess the symptomatic trend of events as compared to the 2002 "SARS" and 2012 "MERS" pandemics. 
CLINICAL CHARACTERISTICS
6/21/21
Christensen J, O'Callaghan K, Sinclair H, et al. | Intern Med J
Aim: To review the evidence on subacute thyroiditis secondary to COVID-19.
CLINICAL CHARACTERISTICS
6/21/21
Fancello V, Hatzopoulos S, Corazzi V, et al. | Int J Immunopathol Pharmacol
Aim: To describe the audio-vestibular disorders related to the newly SARS-CoV-2 infection, including the possible ototoxicity side-effects related to the use of drugs included in the SARS-CoV-2 treatment protocols.
CANDIDATE THERAPEUTICS
6/21/21
Lopez-Verdin S, Prieto-Correa JR, Molina-Frechero N, et al. | Am J Dent
Aim: To review diverse tests that could serve as a screening tool for the dental community to identify patients with potential COVID-19.
DIAGNOSTICS
6/18/21
 | SPOR
Aim: To review the evidence on care models for persons living with long COVID.
6/18/21
Pal R, Singh B, Bhadada SK, et al. | Mycoses
Aim: To review the evidence on COVID-19-associated mucormycosis.
CLINICAL CHARACTERISTICS
6/18/21
Hu Y, Song B | Research Square
Aim: To review the evidence on the relationship between use of antiplatelet agents and major outcomes of COVID-19 patients.
CANDIDATE THERAPEUTICS
6/18/21
Chua PEY, Shah SU, Gui H, et al. | J Investig Med
Aim: To compare clinical presentation, outcomes, and care management among patients with COVID-19 during the early phase of the pandemic.
CLINICAL CHARACTERISTICS
6/18/21
Mitton C, Smith N, Lakzadeh P, et al. | SPOR Evidence Alliance
Aim: To review the evidence on rapid diagnostic testing (RDT) for COVID-19 in a fully vaccinated population.
6/18/21
Adibi A, Golitaleb M, Farrahi-Ashtiani I, et al. | Front Psychiatry
Aim: To investigate GAD's prevalence among HCWs during the COVID-19 pandemic by systematic review and meta-analysis.
UPDATED
MENTAL HEALTH
6/17/21
Zhang R, Gao Y, Xie D, et al. | Epidemiol Infect
Aim: To evaluate the cooperation between countries and institutions and the distribution of outcome measures in registered COVID-19 treatment SRs to provide a reference for researchers to register and carry out COVID-19 SRs.
CANDIDATE THERAPEUTICS
6/17/21
Nopsopon T, Kittrakulrat J, Takkavatakarn K, et al. | PLoS Negl Trop Dis
Aim: To evaluate the prevalence and case fatality rate of COVID-19 in patients with ESRD with RRT.
UPDATED
CLINICAL CHARACTERISTICS
6/17/21
Gabarron E, Oyeyemi S, Wynn R | Bull World Health Organ
Aim: To review misinformation related to coronavirus disease 2019 (COVID-19) on social media during the first phase of the pandemic and to discuss ways of countering misinformation.
INFECTION CONTROL
6/17/21
Yusuf F, Fahriani M, Mamada SS, et al. | F1000Res
Aim: To determine the cumulative prevalence of prolonged gastrointestinal (GI) symptoms, including nausea, vomiting, diarrhea, lack of appetite, abdominal pain, and dysgeusia, in survivors of both mild and severe COVID-19 worldwide and to discuss the potential pathogenesis.  
UPDATED
CLINICAL CHARACTERISTICS
6/17/21
Raina R, Mahajan ZA, Vasistha P, et al. | Blood Purif
Aim: To review the evidence on the incidence and outcomes of AKI in COVID-19 patients.
CLINICAL CHARACTERISTICS
6/17/21
Singh RS, Singh A, Kaur H, et al. | Phytother Res
Aim: To summarize published works of literature on the effects of traditional Indian medicinal plants against acute respiratory infection (COVID-19, SARS, Influenza, and Respiratory syncytial virus infection) and registered clinical trials of traditional Indian herbal medicines in COVID-19.
CANDIDATE THERAPEUTICS
6/17/21
Alimoradi Z, Brostrom A, Tsang HWH, et al. | EClinicalMedicine
Aim: To estimate the magnitude of sleep problems during the COVID-19 pandemic and its relationship with psychological distress.
UPDATED
MENTAL HEALTH
6/16/21
Dong F, Liu H, Dai N, et al. | J Affect Disord
Aim: To investigate the psychological problems on people infected with SARS-CoV-2 during the pandemic.
MENTAL HEALTH
6/16/21
Taheri L, Gheiasi SF, Taher M, et al. | Compr Child Adolesc Nurs
Aim: To identify and summarize the existing evidence on clinical characteristics of COVID-19 in pediatric patients. 
UPDATED
CLINICAL CHARACTERISTICS
6/16/21
Ramanathan K, Shekar K, Ling RR, et al. | Crit Care
Aim: To summarise outcome data during the first year of the pandemic and identify risk factors for an unfavourable outcomes in order to guide clinical decision-making and further research.
UPDATED
CLINICAL CHARACTERISTICS
6/16/21
Di Castelnuovo A, Costanzo S, Cassone A, et al. | Pathog Glob Health
Aim: To evaluate the association between HCQ (with or without azithromycin (AZM)) and total mortality in COVID-19 patients.
CANDIDATE THERAPEUTICS
6/16/21
Saleki K, Yaribash S, Banazadeh M, et al. | Eur J Pharmacol
Aim: To assess the clinical efficacy of IFN-based treatments and combinational therapy with antivirals, corticosteroids, traditional medicine, and other treatments.
CANDIDATE THERAPEUTICS
6/16/21
Maidment I, Young E, MacPhee M, et al. | BMJ Open
Aim: To understand how community pharmacy can most effectively deliver essential and advanced services, with a focus on vaccination, during the pandemic and in the future.
UPDATED
INFECTION CONTROL
6/16/21
Negrini F, de Sire A, Andrenelli E, et al. | Eur J Phys Rehabil Med
Aim: To investigate the literature on rehabilitation services for COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
6/15/21
Buso G, Becchetti C, Berzigotti A | Dig Liver Dis
Aim: To review the evidence on acute splanchnic vein thrombosis in patients with COVID-19.
CLINICAL CHARACTERISTICS
6/15/21
Das P, Mondal S, Pal S, et al. | Indian J Med Microbiol
Aim: To review the evidence on nucleic acid based testing systems for COVID-19.
6/15/21
He Y, Wang J, Ren J, et al. | Front Endocrinol
Aim: To provide a comprehensive overview of the topic of whether COVID-19 can impact on male reproductive system.
CLINICAL CHARACTERISTICS
6/15/21
Dong F, Liu H, Yang M, et al. | Front Psychol
Aim: To investigate the psychosocial impact on healthcare workers (HWs) in China during the pandemic.
MENTAL HEALTH
6/15/21
Iloanusi S, Mgbere O, Essien EJ | J Am Pharm Assoc
Aim: To summarize the available literature on the association between polypharmacy and specific drug classes, and clinical outcomes among COVID-19 patients.
CLINICAL CHARACTERISTICS
6/15/21
Cheng B, Ma J, Yang Y, et al. | Front Pharmacol
Aim: To quantitatively reevaluate the efficacy of corticosteroids on COVID-19. 
CANDIDATE THERAPEUTICS
6/15/21
 | McMaster University Health Forum
Aim: To review the evidence on the effectiveness of the COVID-19 response in Canada.
6/14/21
Li Y, Deng Y, Ye L, et al. | Front Med
Aim: To illuminate the clinical significance of plasma D-dimer in COVID-19 mortality.
CLINICAL CHARACTERISTICS
6/14/21
Pizuorno A, Fierro NA, Copado-Villagrana ED, et al. | BMC Infect Dis
Aim: To study the symptoms and comorbidities that associate with this pandemic in 3 different regions of Mexico.
CLINICAL CHARACTERISTICS
6/14/21
Chan KW, Yu KY, Lee PW, et al. | Front Med
Aim: To assess the association between AKI, mortality, underlying non-communicable diseases, and clinical risk factors.
UPDATED
CLINICAL CHARACTERISTICS
6/14/21
Ibrahimi N, Delaunay-Moisan A, Hill C, et al. | PLoS One
Aim: To compare saliva and nasopharyngeal/oropharyngeal samples for the detection of SARS-CoV-2.
UPDATED
DIAGNOSTICS
6/14/21
Mamun MA | Psychol Res Behav Manag
Aim: To review the Bangladeshi COVID-19-related suicide studies for the first time.
MENTAL HEALTH
6/14/21
Baumhardt M, Dreyhaupt J, Winsauer C, et al. | Dtsch Arztebl Int
Aim: To review the evidence on the impact of lockdown on patients with myocardial infarction during the COVID-19 pandemic.
INFECTION CONTROL
6/14/21
Xin H, Wong JY, Murphy C, et al. | Clin Infect Dis
Aim: To review published estimates of the incubation period distribution with a particular interest in the methodology applied and potential biases.
CLINICAL CHARACTERISTICS
6/14/21
Kirubarajan A, Patel P, Tsang J, et al. | Hum Fertil
Aim: To characterise psychological impacts of the COVID-19 pandemic related to fertility care. 
MENTAL HEALTH
6/14/21
Kay I, Madran B, Keske S, et al. | Clin Microbiol Infect
Aim: To investigate the seroprevalence of SARS-CoV-2 among HCWs and related risk factors.
CLINICAL CHARACTERISTICS
6/14/21
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk of transmission of COVID-19 within post-secondary institutions and the strategies to mitigate on-campus outbreaks.
6/11/21
Harrison SL, Buckley BJR, Rivera-Caravaca JM, et al. | Eur Heart J Qual Care Clin Outcomes
Aim: To consolidate evidence to determine (i) the association between cardiovascular risk factors and health outcomes with coronavirus 2019 (COVID-19); and (ii) the impact of COVID-19 on cardiovascular health.
CLINICAL CHARACTERISTICS
6/11/21
Flumignan RL, Tinôco JDS, Pascoal PI, et al. | Br J Surg
Aim: To assess the effects of prophylactic anticoagulants for people hospitalized with COVID-19.
CANDIDATE THERAPEUTICS
6/11/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence of fit testing and fit checking for testing the protection of a respirator and the factors that influence the outcomes of fit testing.
6/11/21
Akbar M, Pranata R, Wibowo A, et al | Eur Rev Med Pharmacol Sci
Aim: To evaluate the association between the prealbumin and severity and mortality in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/10/21
SeyedAlinaghi S, Mirzapour P, Dadras O, et al. | Eur J Med Res
Aim: To characterize the different variants of SARS-CoV-2 and explore the related morbidity and mortality.
CLINICAL CHARACTERISTICS
6/10/21
Lewis A, Jain R, Frontera J, | J Neuroimaging
Aim: To evaluate cerebrospinal fluid (CSF) results from patients with coronavirus disease 2019 (COVID-19) who had neurological symptoms and had an MRI that showed (1) central nervous system (CNS) hyperintense lesions not attributed to ischemia and/or (2) leptomeningeal enhancement. 
CLINICAL CHARACTERISTICS
6/10/21
Hughes MC, Liu Y, Baumbach A | Gerontol Geriatr Med
Aim: To examine the current literature on the impact of COVID-19 on the health and well-being of informal caregivers for people with dementia. 
UPDATED
MENTAL HEALTH
6/10/21
Nakhlband A, Fakhari A, Azizi H | J Med Virol
Aim: To investigate the efficiency of interferon-alpha against COVID-19.
CANDIDATE THERAPEUTICS
6/10/21
Al Mamun F, Hosen I, Misti JM, et al. | Psychol Res Behav Manag
Aim: To review the evidence on the prevalence and associated risk factors of Bangladeshi students’ mental health sufferings (ie, depression, anxiety, and stress).
MENTAL HEALTH
6/10/21
Guimarães D, Pissarra R, Reis-Melo A, et al. | Int J Clin Pract
Aim: To analyze current literature and reported cases of MISC, concerning its clinical spectrum, complications associated, therapeutic strategies and distinguishing features of other clinical syndromes.
CLINICAL CHARACTERISTICS
6/10/21
Zein AFMZ, Sulistiyana CS, Raffaello WM, et al. | Postgrad Med J
Aim: To evaluate the effect of sofosbuvir/daclatasvir (SOF/DCV) on mortality, the need for intensive care unit (ICU) admission or invasive mechanical ventilation (IMV) and clinical recovery in patients with COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
6/9/21
Asiimwe IG, Pushpakom S, Turner R, et al | Br J Clin Pharmacol
Aim: To continually evaluate the rapidly evolving evidence base on the role of cardiovascular drugs in COVID-19 clinical outcomes (susceptibility to infection, hospitalization, hospitalization length, disease severity, and all-cause mortality).
UPDATED
CLINICAL CHARACTERISTICS
6/9/21
Rodríguez PG, Agapito BP, Rodríguez MSA, et al. | An Pediatr
Aim: To summarize a critical appraisal document of the available evidence on COVID-19, developed with a clinical practice guide format following GRADE methodology.
6/9/21
Abbas M, Zhu NJ, Mookerjee S, et al. | J Hosp Infect
Aim: To explore and describe the current literature in HOCI surveillance.
INFECTION CONTROL
6/9/21
Amani B, Khanijahani A, Amani B | Sci Rep
Aim: To examine the efficacy and safety of HCQ in addition to standard of care (SOC) in COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
6/9/21
Liu DT, Philips KM, Speth MM, et al. | Otolaryngol Head Neck Surg
Aim: To summarize the current state of knowledge on portable high-efficiency particulate air (HEPA) purifiers' effectiveness in eliminating airborne SARS-CoV-2 from indoor environments.
6/9/21
Matli K, Farah R, Maalouf M, et al. | Open Heart
Aim: To highlight the role of thrombosis in COVID-19 and provide new insights on the use of antithrombotic therapy in its management. 
UPDATED
CANDIDATE THERAPEUTICS
6/9/21
Moghadasi AN, Mirmosayyeb O, Barzegar M, et al. | Neurol Sci
Aim: To estimate the pooled prevalence of COVID-19 in patients with MS.
6/8/21
Nikoloski Z, Alqunaibet AM, Alfawaz RA, et al. | BMC Public Health
Aim: To systematize the available evidence on the link between non-communicable diseases and Covid-19.
CLINICAL CHARACTERISTICS
6/8/21
Yang J, D'souza R, Kharrat A, et al. | Acta Obstet Gynecol Scand
Aim: To conduct a living systematic review and meta-analyses of studies reporting pregnancy and neonatal outcomes by comparing the pandemic and pre-pandemic periods.
UPDATED
CLINICAL CHARACTERISTICS
6/8/21
Kurnianto A, Tugasworo D, Andhitara Y, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To evaluate and summarize the scientific literature systematically to explore MT for AIS in the COVID-19 pandemic.
INFECTION CONTROL
6/8/21
Mohan N, Fayyaz MA, Del Rio C, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To evaluate and correlate the neuro-radiological and neurological manifestations in patients diagnosed with SARS-CoV2.To identify neuro-invasive pathways of COVID infection.
CLINICAL CHARACTERISTICS
6/8/21
Sarkar S, Kannan S, Khanna P, et al. | Rev Med Virol
Aim: To explore the utility of RDW in the prognosis of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
6/8/21
Zugaj M, van Ditzhuijzen NS, Golebski K, et al. | Rhinology
Aim: To review the effects of the 7 known human coronaviruses on olfaction to determine if SARS-CoV-2 distinctly affects the olfactory system.
CLINICAL CHARACTERISTICS
6/8/21
Wu KS, Lin PC, Chen YS, et al. | Ann Med
Aim: To investigate the association between statins and COVID-19 outcomes and, if possible, identify the subgroup population that benefits most from statin use.
CANDIDATE THERAPEUTICS
6/8/21
Liang SB, Fang M, Liang CH, et al. | Complement Ther Med
Aim: To evaluate the therapeutic effects and safety of oral CPM for COVID-19.
CANDIDATE THERAPEUTICS
6/7/21
Singh H, Maurya RK, Sharma P, et al. | Int Orthod
Aim: To provide an insight into the prevailing and emerging evidence informing potential risks related to splatter and AGPs, and risk mitigation strategies employed for reducing the potential risk of SARS-CoV-2 transmission from dental bioaerosols.
INFECTION CONTROL
6/7/21
Liu X, Wang H, Shi S, et al. | Postgrad Med J
Aim: To evaluate the association between IL-6 and severe disease and mortality in COVID-19 disease.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Guerrero JI, Barragan LA, Martinez JD, et al. | BMC Infect Dis
Aim: To describe the features of the central and peripheral nervous system involvement by COVID-19 in terms of pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Nascimento I, O Mathuna DP, von Groote TC, et al. | BMC Infect Med
Aim: To collate and summarize all published systematic reviews on the coronavirus disease (COVID-19).
UPDATED
6/7/21
Ruta F, Dal Mas F, Biancuzzi H, et al. | Prof Inferm
Aim: To analyze the literature relating to the impact on the mental health of nurses engaged in the management and care of Covid-19 patients.
MENTAL HEALTH
6/7/21
Messina A, Sanfilippo F, Milani A, et al. | J Crit Care
Aim: To summarise the current knowledge regarding cardiac dysfunction in COVID-19 as assessed by echocardiography, both in ICU and non-ICU subjects.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Sterina E, Hermida AP, Gerberi DJ, et al. | Clin Gerontol
Aim: To examine post-traumatic stress, depression, anxiety, and well-being in older adults under quarantine.
MENTAL HEALTH
6/7/21
Alkatout I, Biebl M, Momenimovahed Z, et al. | Front Oncol
Aim: To investigate the impact of COVID-19 on cancer screening.
INFECTION CONTROL
6/7/21
Zuin M, Rigatelli G, Bilato C, et al. | Acta Cardiol
Aim: To evaluate the pooled incidence of acute HF as a cardiac complication of COVID-19 disease and to estimate the related mortality risk in these patients.
CLINICAL CHARACTERISTICS
6/7/21
Seidu S, Kunutsor SK, Cos X, et al. | Prim Care Diabetes
Aim: To assess the indirect impact of the COVID-19 pandemic on hospitalisations for cardiovascular diseases and their management.
UPDATED
INFECTION CONTROL
6/7/21
Siracusa L, Cascio A, Giordano S, et al. | Ital J Pediatr
Aim: To describe clinical characteristics, laboratory tests, radiological data and outcome of pediatric cases with SARS-CoV-2 infection complicated by neurological involvement.
CLINICAL CHARACTERISTICS
6/7/21
Rogers JP, Watson CJ, Badenoch J, et al. | J Neurol Neurosurg Psychiatry
Aim: To describe the characteristics of the early literature and estimate point prevalences for neurological and neuropsychiatric manifestations.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Salah G, Ahmed A, Hassanain O, et al. | Nutr Cancer
Aim: To understand the role of nutrition in cancer patients during Corvid 19 era.
6/7/21
Subali AD, Wiyono L | Pathog Glob Health
Aim: To review the evidence on RT-LAMP application for rapid identification of SARS-CoV-2 infection compared to the RT-PCR assay.
DIAGNOSTICS
6/7/21
Ao G, Wang Y, Qi X, et al. | Transplant Rev
Aim: To investigate the association between severe or fatal COVID-19 and SOT.
UPDATED
6/7/21
Atieh MA, Guirguis M, Alsabeeha NHM, et al. | Oral Dis
Aim: To systematically evaluate the current literature on the use of saliva test for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and carry out a meta-analysis to determine its diagnostic accuracy.
DIAGNOSTICS
6/7/21
Chong WH, Saha BK, Hu K, et al. | Heart Lung
Aim: To describe the incidence, clinical characteristics, and outcomes of COVID-19-related pneumothorax.
CLINICAL CHARACTERISTICS
6/7/21
Elsayed HH, Hassaballa AS, Ahmed TA, et al. | PLoS One
Aim: To review the evidence on IMV for COVID-associated ARDS to study its outcome among different countries.
UPDATED
CANDIDATE THERAPEUTICS
6/7/21
Mai V, Tan BK, Mainbourg S, et al. | Vascul Pharmacol
Aim: To compare the rate of VTE between COVID-19 and non-COVID-19 cohorts with similar disease severity.
CLINICAL CHARACTERISTICS
6/3/21
Kao Y, Lin K | Diagnostics
Aim: To use computerized tomography (CT)-based radiomics models to differentiate COVID-19 pneumonia from other viral pneumonia infections.
DIAGNOSTICS
6/3/21
 | Health Information and Quality Authority
Aim: To review the international policies and guidelines relating to healthcare personnel who do not avail of COVID-19 vaccination.
6/3/21
Reyes FM, Hache-Marliere M, Karamanis D, et al. | J Clin Med
Aim: To explore the association of COPD and asthma with in-hospital mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
6/3/21
Jimenez-Cebrian AM, Castro-Mendez A, Garcia-Podadera B, et a;/ | J Clin Med
Aim: To analyze and synthesize the published reviews on manifestations of COVID-19 at the foot level. 
UPDATED
CLINICAL CHARACTERISTICS
6/3/21
Arfaras-Melainis A, Tzoumas A, Kokkinidis DG, et al. | J Cardiovasc Dev Dis
Aim: To assess the effect of hydroxychloroquine with or without the addition of azithromycin on the QTc of hospitalized patients with COVID-19.
CANDIDATE THERAPEUTICS
6/3/21
Pormohammad A, Zarei M, Ghorbani S, et al. | Vaccines
Aim: To review the evidence on the clinical features of COVID-19 vaccines to provide a better estimate of their efficacy, side effects and immunogenicity.
INFECTION CONTROL
6/3/21
Leyser M, Marques FJP, do Nascimento OJM | Rev Paul Pediatr
Aim: To perform a systematic literature review to analyze existing data on the neurological effects of coronavirus on newborns.
CLINICAL CHARACTERISTICS
6/3/21
Orozco MFS, Nino-Martinez N, Martinez-Castanon GA, et al. | Medicina
Aim: To summarize the current data about the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its entry factors in oral tissues and cells. 
INFECTION CONTROL
6/3/21
Bellotti L, Zaniboni S, Balducci C, et al. | Int J Environ Res Public Health
Aim: To analyze the effects that the COVID-19 pandemic had on employment and work-related aspects across different age groups.
INFECTION CONTROL
6/3/21
Santana MAC, Cano JAA, Kanan AD, et al. | Medicina
Aim: To contrast the existing evidence regarding the relationship between periodontal disease (PD) and diabetes mellitus (DM) with the possibly increased risk of SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
6/3/21
Kordsmeyer A, Mojtahedzadeh N, Heidrich J, et al. | Int J Environ Res Public Health
Aim: To provide an overview of outbreaks of SARS-CoV-2 on board of cruise, navy or cargo ships, to identify relevant outbreak management techniques, related problems and to derive recommendations for prevention. 
INFECTION CONTROL
6/3/21
Wang R, Liu M, Liu J | Vaccines
Aim: To assess the association between influenza vaccination and SARS-CoV-2 infection and clinical outcomes.
UPDATED
CLINICAL CHARACTERISTICS
6/3/21
Khan DSA, Pirzada AN, Ali A, et al. | Int J Environ Res Public Health
Aim: To investigate the differences in clinical presentation, management, and prognosis of COVID-19 infection in pregnant and non-pregnant women.
UPDATED
CLINICAL CHARACTERISTICS
6/3/21
Chaabane S, Doraiswamy S, Chaabna K, et al. | Children
Aim: To synthesize available data on the impact of school closure during the coronavirus disease 2019 (COVID-19) pandemic on child and adolescent health globally. 
MENTAL HEALTH
6/3/21
Ippolito M, Misseri G, Catalisano G, et al. | Antibiotics
Aim: To estimate the pooled occurrence of ventilator-associated pneumonia (VAP) among patients admitted to an intensive care unit with COVID-19 and mortality of those who developed VAP.
CLINICAL CHARACTERISTICS
6/3/21
Stroehlein JK, Wallqvist J, Iannizzi C, et al.  | Cochrane Database Syst Rev
Aim: To assess whether vitamin D supplementation is effective and safe for the treatment of COVID?19 in comparison to an active comparator, placebo, or standard of care alone, and to maintain the currency of the evidence, using a living systematic review approach.
UPDATED
CANDIDATE THERAPEUTICS
6/2/21
Franchini M, Cruciani M, Mengoli C, et al. | Blood Transfus
Aim: To assess the relationship between the ABO blood group and the occurrence and severity of COVID-19.
CLINICAL CHARACTERISTICS
6/2/21
 | CReSP
Aim: To review the evidence on the impact of redeployment of expertise and public health services towards the COVID-19 pandemic response.
6/2/21
Wilt T, Kaka AS, MacDonald R, et al. | VA Evidence Synthesis Program
Aim: To assess the clinical effectiveness and harms of remdesivir in hospitalized adults with COVID-19.
UPDATED
VA ESP
6/2/21
Patnaik N, Bhatia V, Mishra KG, et al. | J Family Med Prim Care
Aim: To analyse symptoms of pregnant women affected with COVID-19.
6/2/21
Wang MX, Gwee SXW, Pang J | Nutrients
Aim: To systematically assess the associations between micronutrient supplementation or deficiency, with novel coronavirus incidence and disease severity.
UPDATED
CLINICAL CHARACTERISTICS
6/2/21
Schulte EC, Hauer L, Kunz AB, et al. | Eur J Neurol
Aim: To review cases of ATM described in the context of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection.
CLINICAL CHARACTERISTICS
6/2/21
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the prevalence of household food insecurity in North America as a result of the COVID-19 and associated public health measures.
6/1/21
Hempel S, Burke RV, Hochman M, et al. | J Clin Epidemiol
Aim: To review evidence-based approaches for evaluation of strategies for policymakers.
6/1/21
Grove A, Osokogu O, Al-Khudairy L, et al. | BMJ Open
Aim: To systemically review and critically appraise published studies of the association between vitamin D supplementation or serum vitamin D level and susceptibility to SARS-CoV-2 infection or COVID-19, including clinical course, morbidity and mortality outcomes.
UPDATED
CLINICAL CHARACTERISTICS
6/1/21
Dumitrascu F, Branje KE, Hladkowicz ES, et al. | J Am Geriatr Soc
Aim: To identify, describe, and synthesize studies reporting the association of frailty with outcomes (informed by the Institute for Healthcare Improvement's Triple Aim [health, resource use, and experience]) in individuals with COVID-19.
CLINICAL CHARACTERISTICS
6/1/21
Carroll E, Melmed KR, Frontera J, et al. | Seizure
Aim: To review the CSF results in published case reports and case series of patients with COVID-19 who had seizures to evaluate for evidence of viral neuroinvasion.
CLINICAL CHARACTERISTICS
6/1/21
Manoharan L, Olliaro P, Horby PW, et al. | Trials
Aim: To critically appraise significant design features and alignment of study populations to clinical and public health uses, and describe candidate chemoprophylactic agents.
INFECTION CONTROL
6/1/21
da Silva RP, Goncalves JIB, Zanin RF, et al. | Front Immunol
Aim: To summarize the available evidence of the association of plasma protein levels of type I IFN with the severity of COVID-19.
CLINICAL CHARACTERISTICS
6/1/21
Seth T, Elavarasi A, Sahoo RK, et al. | Natl Med J India
Aim: To synthesize the available data on CP therapy for treatment of Covid-19 to study the efficacy and safety outcomes.
CANDIDATE THERAPEUTICS
6/1/21
Ayouni I, Maatoug J, Dhouib W, et al.  | BMC Public Health
Aim: To evaluate the implemented public health interventions to control the spread of the outbreak of COVID-19.
UPDATED
INFECTION CONTROL
6/1/21
Prasad M, Elavarasi A, Madan K, et al. | Natl Med J India
Aim: To review the evidence on the use of antivirals for Covid-19.
CANDIDATE THERAPEUTICS
6/1/21
Chou R, Dana T, Buckley D, et al. | Ann Intern Med
Aim: To examine the burden of SARS-CoV-2, SARS-CoV-1, and Middle Eastern respiratory syndrome (MERS)-CoV on HCWs and risk factors for infection, using rapid and living review methods.
UPDATED
WHO COLLABORATIVE
6/1/21
Shetty RM, Namachivayam AK | Indian J Crit Care Med
Aim: To review the evidence for the benefit of chloroquine/hydroxychloroquine in the treatment of patients with COVID-19.
CANDIDATE THERAPEUTICS
6/1/21
Manabe T, Kambayashi D, Akatsu H, et al. | BMC Infect Dis
Aim: To review systematically on the application of favipiravir for patients with COVID-19 to identify empirical evidence of its efficacy.
CANDIDATE THERAPEUTICS
6/1/21
Bolia R, Goel AD, Badkur M, et al. | J Trop Pediatr
Aim: To determine the GI manifestations of pediatric COVID-19 and to evaluate their role as risk factors for a severe clinical course.
CLINICAL CHARACTERISTICS
6/1/21
Lee Y, Lui LMW, Chen-Li D, et al. | J Affect Disord
Aim: To evaluate the impact of the COVID-19 pandemic and government response on measures of depressive symptom presence and severity based on published studies.
UPDATED
MENTAL HEALTH
6/1/21
Kaur H, Thakur JS, Paika R, et al. | Asian Pac J Cancer Prev
Aim: To explore the prevalence of comorbidities among cancer patients with SARS CoV-2 infection and their impact on mortality.
UPDATED
CLINICAL CHARACTERISTICS
6/1/21
Muehlschlegel P, Parkinson E, Chan RYL, et al. | J Glob Health
Aim: To comprehensively evaluate biopsychosocial consequences after lockdown measures are lifted and identify strategies to successfully negotiate the transition out of COVID-19 related lockdowns.
UPDATED
MENTAL HEALTH
6/1/21
Amani B, Khanijahani A, Amani B, et al. | J Pharm Pharm Sci
Aim: To provide the latest evidence on the efficacy and safety of lopinavir/ritonavir compared to other treatment options for COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
6/1/21
Radovanovic D, Coppola S, Franceschi E, et al. | J Crit Care
Aim: To analyse mortality and intubation rates in COVID-19 patients treated with NIV/CPAP.
CANDIDATE THERAPEUTICS
6/1/21
Tagliamento M, Agostinetto E, Bruzzone M, et al. | Crit Rev Oncol Hematol
Aim: To estimate the mortality in patients with cancer and SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
6/1/21
Singh S, Verma N, Kanaujia R, et al. | Mycoses
Aim: To synthesize the results of primary studies on CAPA and to provide pooled mortality estimators of in-hospital mortality of the disease and potential predictors of outcome.
CLINICAL CHARACTERISTICS
6/1/21
Almazroa A, Alamri S, Alabdulkader B, et al. | Int Health
Aim: To review the evidence on ocular transmission and manifestations of SARS-CoV-2.
CLINICAL CHARACTERISTICS
6/1/21
Bekele F, Machessa DF, Sefera B | Ann Med Surg
Aim: To summarize the prevalence and associated factors of the psychological impact of COVID-19 among the health care workers (HCWs), patients and communities in Ethiopia.
MENTAL HEALTH
6/1/21
Zawawi A, Naser AY, Alwafi H, et al. | Front Immunol
Aim: To evaluate the inflammatory cytokines profile associated with severe human coronavirus diseases, including three stains: MERS-CoV, SARS-CoV SARS-CoV-2, in severe patients.
UPDATED
CLINICAL CHARACTERISTICS
6/1/21
O Murchu E, Byrne P, Carty PG, et al. | Rev Med Virol
Aim: To evaluate the risk and relative risk of SARS-CoV-2 reinfection over time, comparing previously infected individuals to those without evidence of prior infection.
CLINICAL CHARACTERISTICS
6/1/21
Tasavon Gholamhoseini M, Yazdi-Feyzabadi V, Goudarzi R, et al. | J Pharm Pharm Sci
Aim: To assess the safety and efficacy of remdesivir in adult patients with COVID-19.
CANDIDATE THERAPEUTICS
6/1/21
Hou H, Li Y, Zhang P, et al. | Nicotine Tob Res
Aim: To explore the association between smoking and mortality of coronavirus disease 2019 (COVID-19) patients utilizing a quantitative meta-analysis on the basis of adjusted effect estimates.
CLINICAL CHARACTERISTICS
6/1/21
Kabrah SM, Kabrah AM, Flemban AF, et al. | Transfus Apher Sci
Aim: To evaluate the existing evidence on the susceptibility of the ABO blood group to COVID-19 infection.
CLINICAL CHARACTERISTICS
6/1/21
Peters A, Palomo R, Ney H, et al. | Antimicrob Resist Infect Control
Aim: To review the various methods for decontamination and the potential issues to be taken into account when deciding to reuse masks. 
INFECTION CONTROL
6/1/21
Melesse DY, Chekol WB | Clin Nutr Open Sci
Aim: To review the evidence on the management of critically ill patients with COVID-19 in ICU in resource limiting settings.
CANDIDATE THERAPEUTICS
5/31/21
 | EUnetHTA
Aim: To review the evidence on the use of darunavir for the treatment for COVID-19.
5/31/21
 | EUnetHTA
Aim: To review the evidence on the use of favipiravir for the treatment for COVID-19.
5/28/21
Nasserie T, Hittle M, Goodman SN | JAMA Netw Open
Aim: To conduct a systematic review of studies examining the frequency and variety of persistent symptoms after COVID-19 infection.
CLINICAL CHARACTERISTICS
5/28/21
Staibano P, Levin M, McHugh T, et al. | JAMA Otolaryngol Head Neck Surg
Aim: To evaluate the association of tracheostomy with COVID-19 patient outcomes and the risk of SARS-CoV-2 transmission among health care professionals (HCPs).
UPDATED
INFECTION CONTROL
5/28/21
Iqbal FM, Lam K, Sounderajah V, et al. | EClinicalMedicine
Aim: To characterise the clinical features between acute and chronic post-COVID syndrome.
UPDATED
CLINICAL CHARACTERISTICS
5/28/21
Karam M, Althuwaikh S, Alazemi M, et al. | JRSM Open
Aim: To compare the performance of chest computed tomography (CT) scan versus reverse transcription polymerase chain reaction (RT-PCR) as the reference standard in the initial diagnostic assessment of coronavirus disease 2019 (COVID-19) patients.
DIAGNOSTICS
5/28/21
Kastora S, Kounidas G, Perrott S, et al. | EClinicalMedicine
Aim: To quantify the impact of clinical frailty scale (CFS) by increasing severity of frailty and to identify other personal prognostic factors associated with increased mortality from COVID-19.
CLINICAL CHARACTERISTICS
5/28/21
Arienti C, Lazzarini S, Pollini E, et al. | J Rehabil Med
Aim: To assess the effectiveness of rehabilitation interventions in adults with multiple organ dysfunction syndrome.
CANDIDATE THERAPEUTICS
5/28/21
Panda S, Nanda R, Tripathy PK, et al. | J Family Med Prim Care
Aim: To summarize the alteration in the immunological and inflammatory markers of COVID-19 cases reported in currently available observational studies and their associations with the severity of disease process.
CLINICAL CHARACTERISTICS
5/28/21
Fahmy OH, Daas FM, Salunkhe V, et al. | Crit Care Explor
Aim: To retrieve and report the findings of postmortem studies including the histopathologic data of deceased coronavirus disease 2019 patients and to review the manifestations of coronavirus disease 2019–associated thrombotic pathologies reported in the recent literature.
CLINICAL CHARACTERISTICS
5/28/21
Kaur U, Chakrabarti SS, Patel TK | Ther Adv Drug Saf
Aim: To provide a pooled estimate of the effect of RAAS blockers on COVID-19 outcomes.
CANDIDATE THERAPEUTICS
5/28/21
Ali ST, Yeung A, Shan S, et al. | Clin Infect Dis
Aim: To summarize the existing evidence on serial interval distributions and delays in case isolation for COVID-19.
INFECTION CONTROL
5/28/21
Sahilu T, Sheleme T, Melaku T | Interdiscip Perspect Infect Dis
Aim: To summarize the current evidence of the severity and mortality associated with steroid therapy for patients with COVID-19. 
UPDATED
CANDIDATE THERAPEUTICS
5/28/21
de Sousa Neto AR, de Carvalho ARB, de Oliveira EMN, et al. | Rev Gaucha Enferm
Aim: To identify symptoms of COVID-19 in adults in the scientific literature.
CLINICAL CHARACTERISTICS
5/28/21
Hassanipour S, Arab-Zozani M, Amani B, et al. | Sci Rep
Aim: To investigate the efficacy and safety of Favipiravir in treatment of COVID-19 patients.
CANDIDATE THERAPEUTICS
5/27/21
 | Saskatchewan Health Authority
Aim: To review the evidence on what other jurisdictions are offering for incentive-based COVID-19 vaccine campaigns.
5/26/21
Pang C, Hou Q, Yang Z, et al. | Clin Transl Imaging
Aim: To comprehensively assess the diagnostic value of chest CT for COVID-19.
DIAGNOSTICS
5/24/21
Vanderlind WM, Rabinovitz BB, Miao IY, et al. | Curr Opin Psychiatry
Aim: To synthesize available literature on psychiatric and cognitive characteristics of community-dwelling survivors of COVID-19 infection.
MENTAL HEALTH
5/24/21
Hooper JJ, Saulsman L, Hall T, et al. | BMJ Open
Aim: To identify and summarise recent early psychological intervention programmes that were administered to prevent or minimise psychological harm in frontline responders.
MENTAL HEALTH
5/24/21
Massarvva T | Epidemiol Health
Aim: To systematically review up-to-date studies reporting on the clinical outcomes of COVID-19 amongst HIV patients.
CLINICAL CHARACTERISTICS
5/24/21
Barzegar M, Mirmosayyeb O, Gajarzadeh M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To systematically review the literature on COVID-19 in patients with multiple sclerosis (MS).
CLINICAL CHARACTERISTICS
5/24/21
Shah S, Akhade K, Ganguly S, et al. | J Family Med Prim Care
Aim: To summarize the major patterns of dermatological manifestations associated with SARS-CoV-2 virus infection.
CLINICAL CHARACTERISTICS
5/24/21
Garcia-Azorin D, Seeher KM, Newton CR, et al. | J Neurol
Aim: To evaluate the particular impact on neurological services.
INFECTION CONTROL
5/24/21
Chmielewska B, Barratt I, Townsend R, et al. | Lancet Glob Health
Aim: To assess the collateral effects on maternal, fetal, and neonatal outcomes of the global COVID-19 pandemic.
CLINICAL CHARACTERISTICS
5/24/21
Mangkuliguna G, Glendardi G, Susanto N, et al. | Tuberc Respir Dis
Aim: To investigate the efficacy and safety of Azithromycin in COVID-19 patients.
UPDATED
CANDIDATE THERAPEUTICS
5/24/21
Patel TK, Patel PB, Barvaliya M, et al. | J Infect Public Health
Aim: To evaluate a pooled effect of lopinavir-ritonavir on mortality, virological cure, radiological improvement and safety profile in COVID-19 patients.
CANDIDATE THERAPEUTICS
5/24/21
SeyedAlinaghi S, Mehrtak M, MohsseniPour M, et al. | Eur J Med Res
Aim: To investigate the available evidence for the genetic susceptibility to COVID-19.
CLINICAL CHARACTERISTICS
5/24/21
Salamanna F, Veronesi F, Martini L, et al. | Front Med
Aim: To assess the current evidence on the long-term symptoms in COVID-19 patients.
CLINICAL CHARACTERISTICS
5/24/21
Abate SM, Chekole YA, Estifanos MB, et al. | Clin Nutr ESPEN
Aim: To investigate the prevalence and outcome of malnutrition among patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/24/21
Mathew HR, Choi MY, Parkins MD, et al. | BMC Pulm Med
Aim: To systematically survey published accounts of COVID-19 in CF and determine if individuals with CF are disproportionally affected by SARS-CoV-2 and development of COVID-19.
CLINICAL CHARACTERISTICS
5/24/21
Li W, Zhang H, Zhang C, et al. | Front Psychol
Aim: To review the evidence on the prevalence of different psychological states during the early stage of the COVID-19 epidemic in China.
UPDATED
MENTAL HEALTH
5/24/21
Snow TAC, Saleem N, Ambler G, et al. | Intensive Care Med
Aim: To ascertain the benefit of IL-6 blockade with tocilizumab for COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
5/21/21
Singhal S, Kumar P, Singh S, et al. | BMC Geriatr
Aim: To review the evidence on the clinical characteristics of older COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/21/21
Piechotta V, Iannizzi C, Chai KL, et al. | Cochrane Database Syst Rev
Aim: To assess whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe in the treatment of people with COVID?19.
UPDATED
CANDIDATE THERAPEUTICS
5/21/21
Pulakurthi YS, Pederson JM, Saravu K, et al. | Medicine
Aim: To investigate the clinical outcomes associated with corticosteroid treatment of COVID-19.
CANDIDATE THERAPEUTICS
5/21/21
O'Leary N, Kingston L, Griffin A, et al. | Scand J Public Health
Aim: To document the healthcare policies developed during the initial wave of widespread COVID-19 transmission in Ireland. 
5/21/21
Bzeizi K, Abdulia M, Mohammed N, et al. | Sci Rep
Aim: To assess the available evidence on the clinical effects of SARS-CoV-2 on liver function laboratory tests and coagulation profile in affected individuals. 
UPDATED
CLINICAL CHARACTERISTICS
5/21/21
Xiong X, Chi J, Gao Q | Thromb J
Aim: To determine the prevalence and risk factors of thrombotic events on COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/21/21
Bin Nafisah SA, Mzahim BY, Aleid BS, et al. | Ann Thorac Med
Aim: To assess the occurrence of disease transmission to HCPs from the performance aerosol-generating procedures (AGPs).
INFECTION CONTROL
5/21/21
Avni T, Leibovici L, Cohen I, et al. | QJM
Aim: To evaluate whether IL-6 inhibitor tocilizumab (TCZ) reduces mortality among hospitalized COVID-19 patients.
CANDIDATE THERAPEUTICS
5/20/21
Wang J, Kaperak C, Sato T, et al. | J Investig Med
Aim: To identify cases infected with different genetic strains of SARS-CoV-2 confirmed by polymerase-chain reaction and viral genome sequencing.
UPDATED
DIAGNOSTICS
5/20/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on COVID-19 vaccination before elective surgery, including any recommendations regarding the timing of vaccination.
5/20/21
Hampson G, Stone M, Lindsay JR, et al. | Calcif Tissue Int
Aim: To provide information on how the COVID-19 pandemic has impacted the diagnosis and management of osteoporosis.
5/20/21
Alcock H, Moppett EA, Moppett IK | Bone Jt Open
Aim: To understand the impact of coexistent hip fracture and SARS-CoV-2 for informed decision-making at patient and service levels.
CLINICAL CHARACTERISTICS
5/20/21
Manoharan L, Cattrall JW, Harris C, et al. | PLoS One
Aim: To summarize the early literature on clinical characteristics of patients admitted to hospital, and evaluates the quality of evidence produced during the initial stages of the pandemic.
CLINICAL CHARACTERISTICS
5/20/21
Minozzi S, Saulle R, Amato L, et al. | Recenti Prog Med
Aim: To summarize the data of a systematic review on the impact of the 2020 school closure and social distances measures implemented in response to COVID-19 pandemic on youths' physical health and psychological wellbeing. 
MENTAL HEALTH
5/20/21
Minozzi S, Saulle R, Amato L, et al. | Recenti Prog Med
Aim: To summarize the most relevant data of a systematic review on the impact of the 2020 school closure and social distances measures implemented in response to COVID-19 pandemic on youths physical health and psychological wellbeing.
MENTAL HEALTH
5/20/21
Saulle R, Minozzi S, Amato L, et al. | Recenti Prog Med
Aim: To summarize the most relevant data from a literature systematic review on the impact on youths' physical health of the 2020 school closure and social distances measures implemented in response to COVID-19 pandemic.
5/20/21
Haghpanah A, Masjedi F, Salehipour M, et al. | Prostate Cancer Prostatic Dis
Aim: To explore the potential mechanisms of SARS-CoV-2 in targeting the prostate gland, leading to exacerbation of benign prostatic hyperplasia (BPH) symptoms and greater risks of BPH complications such as acute urinary retention.
CLINICAL CHARACTERISTICS
5/20/21
Pannone G, Caponio VCA, De Stefano IS, et al. | Infect Agent Cancer
Aim: To summarize lung histopathological characteristics of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/20/21
Ishfaq A, Farooq SMY, Goraya A, et al. | Eur J Radiol Open
Aim: To identify the role of High-Resolution Computed Tomography chest and summarize characteristics of chest CT imaging for the diagnosis and evaluation of SARS-CoV-2 patients.
DIAGNOSTICS
5/20/21
Chen C, Hu F, Wei J, et al. | Leukemia
Aim: To determine safety and efficacy of tocilizumab in persons with coronavirus disease-2019 (COVID-19).
CANDIDATE THERAPEUTICS
5/20/21
Dhar D, Dey T, Samim MM, et al. | Pediatr Res
Aim: To review the evidence on the demographic profile, clinical characteristics, complications, management, and prognosis of MIS-C associated with COVID-19.
CLINICAL CHARACTERISTICS
5/20/21
Wei Q, Lin H, Wei R, et al. | Infect Dis Poverty
Aim: To review the evidence on tocilizumab treatment for COVID-19 patients.
CANDIDATE THERAPEUTICS
5/19/21
Barkas F, Ntekouan SF, Kosmidou M, et al. | Rheumatology
Aim: To assess the efficacy and safety of anakinra in adult hospitalized non-intubated patients with COVID-19.
CANDIDATE THERAPEUTICS
5/19/21
Campbell H, Wood AC | Curr Nutr Rep
Aim: To examine the evidence that the dietary quality of children changed between the period preceding the COVID-19 pandemic and the first year during the pandemic.
5/19/21
Scheiner NS, Smith AK, Wohlleber M, et al. | J Acad Consult Liaison Psychiatry
Aim: To review the extant literature describing catatonia in the setting of COVID-19 disease and highlight commonalities among the cases.
CLINICAL CHARACTERISTICS
5/19/21
Himmels JPW, Borge TC, Brurberg KG, et al. | Norwegian Institute of Public Health
Aim: To review the evidence on the risk factors for severe COVID-19 disease.
5/19/21
Azab MA, Azzam AY | Brain Disord
Aim: To perform a meta-analysis of the available published data concerning the management of glioma patients in the published literature from the beginning of the pandemic to the end of 2020 concerning the number of operated surgeries, postoperative complications, and mortality outcomes.
CLINICAL CHARACTERISTICS
5/19/21
Quesada JA, Lopez-Pineda A, Gil-Guillen VF, et al. | Rev Clin Esp
Aim: To provide a more accurate estimate of the incubation period of COVID-19.
CLINICAL CHARACTERISTICS
5/19/21
Bekele F, Hajure M | SAGE Open Med
Aim: To summarize the magnitudes and determinants of the psychological impact of coronavirus among health care professionals.
MENTAL HEALTH
5/18/21
 | EUnetHTA
Aim: To review the evidence on the use of interferon and novaferon for the treatment for COVID-19.
5/18/21
 | EUnetHTA
Aim: To review the evidence on the use of sarilumab for the treatment for COVID-19.
5/17/21
Bircakova B, Bruha R, Lambert L, et al. | Scand J Gastroenterol
Aim: To review clinical and laboratory findings in patients with SARS-Cov-2 (COVID-19) related acute pancreatitis.
CLINICAL CHARACTERISTICS
5/17/21
Cardwell K, O'Neill SM, Tyner B, et al. | Rev Med Virol
Aim: To identify measures available to support those in isolation or quarantine during the coronavirus disease 2019 (Covid-19) pandemic, and determine their effectiveness in improving adherence to these recommendations and or reducing transmission. 
INFECTION CONTROL
5/17/21
Hernandez-Perez A, Garcia-Gomez L, Rodriguez-Llamazares S, et al. | Salud Publica Mex
Aim: To describe the possible risks associated to smoking in the spread and complications of Covid-19, emphasizing in the benefits of quitting smoking.
CLINICAL CHARACTERISTICS
5/17/21
 | CADTH
Aim: To review the evidence on the availability, accuracy, safety, cost, and other considerations for using self-administered screening tests at home for severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2.
5/17/21
 | EUnetHTA
Aim: To review the evidence on the use of canakinumab for the treatment for COVID-19.
5/17/21
McDonald I, Murray SM, Reynolds CJ, et al. | NPJ Vaccines
Aim: To evaluate pertinent SARS-CoV-1, MERS-CoV and SARS-CoV-2 studies in humans and NHP.
INFECTION CONTROL
5/17/21
 | EUnetHTA
Aim: To review the evidence on the use of convalescent plasma treatment for COVID-19.
5/17/21
Gebreheat G, Teame H | J Multidiscip Healthc
Aim: To identify the main ethical challenges faced by nurses during COVID-19 pandemic.
5/17/21
 | EUnetHTA
Aim: To review the evidence on the use of gimsilumab for the treatment for COVID-19.
5/17/21
Nochaiwong S, Ruengorn C, Thavorn K, et al. | Sci Rep
Aim: To provide a contemporary global prevalence of mental health issues among the general population amid the coronavirus disease-2019 (COVID-19) pandemic. 
UPDATED
MENTAL HEALTH
5/17/21
 | EUnetHTA
Aim: To review the evidence on the use of high-dose vitamin D for the treatment for COVID-19.
5/17/21
Lei H, Yang Y, Zhou W, et al. | Lung Cancer
Aim: To provide precise estimates of the mortality rate of COVID-19 patients with lung cancer and other tumors.
UPDATED
5/17/21
 | EUnetHTA
Aim: To review the evidence on the use of mavrilimumab for the treatment for COVID-19.
5/17/21
 | EUnetHTA
Aim: To review the evidence on the use of molnupiravir for the treatment for COVID-19.
5/17/21
 | EUnetHTA
Aim: To review the evidence on the use of nafamostat for the treatment for COVID-19.
5/17/21
Shao SC, Lai CC, Chen YH, et al. | Age Aging
Aim: To summarize the evidence on prevalence, incidence and mortality of delirium in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/17/21
El-Menyar A, Mekkodathil A, Asim M, et al. | Sci Prog
Aim: To explore the standards for research conduction, publications and retraction of articles related to COVID-19 pharmacotherapy research during the pandemic.
5/17/21
Wingert A, Pillay J, Gates M, et al. | BMJ Open
Aim: To determine the magnitude of association between potential risk factors and severity of COVID-19, to inform vaccine prioritisation in Canada.
CLINICAL CHARACTERISTICS
5/17/21
Severo Bem Junior L, do Rego Aquino PL, Nunes Rabelo N, et al. | J Neurol Res
Aim: To reveal the current knowledge regarding CNS manifestation in SARS-CoV-2. 
CLINICAL CHARACTERISTICS
5/17/21
Mitra S, Ling RR, Yang IX, et al. | Ann Acad Med Singap
Aim: To review the evidence on COVID-19-induced coagulopathy.
CLINICAL CHARACTERISTICS
5/17/21
 | EUnetHTA
Aim: To review the evidence on the use of solnatide for the treatment for COVID-19.
5/17/21
 | EUnetHTA
Aim: To review the evidence on the use of tocilizumab for the treatment for COVID-19.
5/14/21
Biswas M, Most SKK | Sci Rep
Aim: To assess aggregated risk by investigating the association of ACEIs/ARBs users against non-users of ACEIs/ARBs with the risk of mortality or severe clinical manifestations or magnitude of SARS-CoV-2 test positivity in COVID-19 patients.
CLINICAL CHARACTERISTICS
5/14/21
Soeroto AY, Purwiga A, Pranggono EH, et al. | Asian Pac J Allergy Immunol
Aim: To investigate the association between asthma and composite poor outcome in patients with coronavirus disease (COVID-19).
CLINICAL CHARACTERISTICS
5/14/21
Wu T, Yu P, Li Y, et al. | J Asthma
Aim: To analyze the association between COVID-19 and asthma.
CLINICAL CHARACTERISTICS
5/14/21
Antwi HA, Zhou L, Xu X, et al. | Healthcare
Aim: To examine the extent to which companies are able to balance their business interest with social interest through health-related CSR and how knowledge of them can help explain the potential impact of COVID-19.
5/14/21
Munir MA, Tandiabang PA, Setyawati T, et al. | Transfus Clin Biol
Aim: To analyze the bioethical issues surrounding the potential use and study of convalescent plasma therapy in COVID-19.
CANDIDATE THERAPEUTICS
5/14/21
Lim KH, Soong F, Low YF, et al. | J Clin Virol
Aim: To determine the clinical manifestations of neonatal COVID-19 and outcomes based on severity groups. 
CLINICAL CHARACTERISTICS
5/14/21
De Crescenzo F, Amato L, Cruciani F, et al. | Front Pharmacol
Aim: To assess the comparative efficacy and safety of pharmacological interventions for COVID-19.
UPDATED
CANDIDATE THERAPEUTICS
5/14/21
Mourmouris P, Tzelves L, Roidi C, et al. | Osong Public Health Res Perspect
Aim: To identify the potential and definite sources of transmission of coronavirus disease 2019 (COVID-19).
INFECTION CONTROL
5/14/21
Kwee RM, Adams HJA, Kwee TC | Radiol Cardiothorac Imaging
Aim: To determine the diagnostic performance of the COVID-19 Reporting and Data System (CO-RADS) and the Radiological Society of North America (RSNA) categorizations in patients with clinically suspected coronavirus disease 2019 (COVID-19) infection.
DIAGNOSTICS
5/14/21
Zhan H, Chen H, Liu C, et al. | Clin Appl Thromb Hermost
Aim: To assess the predictive value of D-dimer for the severity, mortality and incidence of venous thromboembolism (VTE) events in COVID-19 patients.
DIAGNOSTICS
5/14/21
Khodeir MM, Shabana HA, Alkhamiss AS, et al. | J Infect Public Health
Aim: To review different biomarkers to systematically analyze these values to evaluate whether are they are correlated with the severity of COVID-19 disease and so their ability to be a predictor for progression.
CLINICAL CHARACTERISTICS
5/14/21
Siow I, Lee KS, Zhang JJY, et al. | Eur J Neurol
Aim: To describe the incidence, clinical course and outcomes of patients who suffer from encephalitis as a complication of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/14/21
Chambergo-Michilot D, Barros-Sevillano S, Rivera-Torrejon O, et al. | Eur J Neurol
Aim: To systematically review the factors associated with COVID-19 in people with PD.
UPDATED
CLINICAL CHARACTERISTICS
5/14/21
Heath L, Carey M, Lowney AC, et al.  | Palliat Med
Aim: To determine the dose ranges of pharmacological interventions commonly used to manage symptoms in adult patients dying of COVID-19, establish how effectiveness of these interventions was measured, and whether the pharmacological interventions were effective.
UPDATED
CANDIDATE THERAPEUTICS
5/14/21
Paternoster G, Bertini P, Innelli P, et al. | J Cardiothorac Vasc Anesth
Aim: To describe the features of right ventricular impairment and pulmonary hypertension in coronavirus disease (COVID-19) and assess their effect on mortality.
UPDATED
CLINICAL CHARACTERISTICS
5/14/21
James PT, Ali Z, Armitage AE, et al. | J Nutr
Aim: To review the latest evidence on how malnutrition across all its forms (under- and overnutrition and micronutrient status) may influence both susceptibility to, and progression of, COVID-19.
CLINICAL CHARACTERISTICS
5/13/21
Nobari NN, Seirafianpour F, Dodangeh M, et al. | Exp Dermatol
Aim: To collect the mucocutaneous histopathologic data of COVID-19 patients for future investigations and interpretations. 
CANDIDATE THERAPEUTICS
5/13/21
Kang S, Gong X, Yuan Y | Epidemiol Infect
Aim: To systematically assess the association between smoking and cardiovascular disease and disease progression among novel coronavirus pneumonia (COVID-19) cases.
UPDATED
CLINICAL CHARACTERISTICS
5/13/21
Ahammed T, Anjum A, Rahman MM, et al. | Health Sci Rep
Aim: To estimate the R0 and CFR of COVID-19 and assess whether the parameters vary in different regions of the world.
UPDATED
INFECTION CONTROL
5/13/21
Martimbianco ALC, Pacheco RL, Bagattini AM, et al. | Int J Clin Pract
Aim: To identify, systematically evaluate and summarise the best available evidence on the frequency of long COVID (post-acute COVID-19 syndrome), its clinical manifestations and the criteria used for diagnosis.
UPDATED
CLINICAL CHARACTERISTICS
5/13/21
Zaccari V, D'Arienzo MC, Caiazzo T, et al. | Front Psychiatry
Aim: To review all the empirical contributions published after March 2020 that dealt with the impact of the COVID-19 pandemic on OCD in adults, children and adolescents.
MENTAL HEALTH
5/13/21
Okoli GN, Rabbani R, Copstein L, et al. | Infect Dis
Aim: To review the evidence on the treatment of COVID-19 with remdesivir.
CANDIDATE THERAPEUTICS
5/13/21
Moezzi M, Shirbandi K, Shahvandi HK, et al. | Inform Med Unlocked
Aim: To summarize all the data currently available on the AI-assisted CT-Scan prediction accuracy for COVID-19.
DIAGNOSTICS
5/12/21
Round T, L'Esperance V, Bayly J, et al. | Br J Cancer
Aim: To review the evidence on delivering lung cancer care during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
5/12/21
Lin Z, Chen J, Han S | Expert Rev Anticancer Ther
Aim: To assess whether anti-cancer therapies such as surgery, chemotherapy, immunotherapy, and targeted therapy will increase the severity and mortality of cancer patients with COVID-19.
5/12/21
Azene AG, Workie MS, Aragaw AM | Curr Ther Res Clin Exp
Aim: To assess the pooled status of knowledge, attitude, and prevention practices regarding COVID -19 in Ethiopia.
INFECTION CONTROL
5/12/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on vaccine hesitancy.
5/11/21
Lim XY, Chan JCW, Tan TYC, et al. | Natural Product Com
Aim: To collate and analyze the antiviral evidence for A. paniculata, andrographolide, and its analogs, specifically against SARS-CoV-2. 
5/11/21
Shorey SY, Ng ED, Chee CYI | Scand J Public Health
Aim: To examine the prevalence of antenatal and postnatal anxiety and depressive symptoms among pregnant women and postpartum mothers during the COVID-19 period.
MENTAL HEALTH
5/11/21
Keshavarz P, Yazdanpanah F, Azhdari S, et al. | J Med Virol
Aim: To demonstrate the relationship between severely ill cases of MIS-C and COVID-19.
CLINICAL CHARACTERISTICS
5/11/21
Galanis P, Vraka I, Fragkou D, et al. | Am J Infect Control
Aim: To assess the impact of PPE use on HCWs' physical health and we examined factors related to a greater risk of adverse events due to PPE use.
INFECTION CONTROL
5/11/21
Rachel JB, Gururaj N, Smitha T, et al. | J Oral Maxillofac Pathol
Aim: To understand study the strain variants, all possible modes of transmission, pathogenesis, and manifestations mentioned in predominant literature published during the pandemic.
DIAGNOSTICS
5/11/21
Born J, Beymer D, Rajan D, et al. | Patterns
Aim: To address the utility of AI in imaging for COVID-19 patient care.
DIAGNOSTICS
5/11/21
Zippi M, Fiorino S, Budriesi R, et al. | World J Clin Cases
Aim: To identify studies on the relationship between the intake of PPIs and coronavirus disease 2019 (COVID-19) in patients affected by SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
5/11/21
Las Casas Lima MH, Cavalcante ALB, Leão SC | Braz J Otorhinolaryngol
Aim: To analyze current scientific evidence intended to elucidate the pathophysiological relationship between COVID-19 and the cause of olfactory disorders.
CLINICAL CHARACTERISTICS
5/11/21
Jaffe TA, Hayden E, Uscher-Pines L, et al. | J Am Coll Emerg Physicians Open
Aim: To describe the landscape of telehealth initiatives in emergency care that have been described during the coronavirus disease 2019 pandemic.
INFECTION CONTROL
5/11/21
Oscanoa TJ, Amado J, Vidal X, et al. | Adv Respir Med
Aim: To conduct a metanalysis of the association between 25-hydroxyvitamin D (25(OH)D) concentration and SARS-CoV-2 infection severity or mortality.
CLINICAL CHARACTERISTICS
5/11/21
Wijaya I, Andhika R, Huang I, et al. | Clin Epidemiol Glob Health
Aim: To assess the efficacy of JAK inhibitors in terms of clinical outcome, including mortality, clinical improvement, and clinical deterioration among hospitalized COVID-19 patients.
UPDATED
CANDIDATE THERAPEUTICS
5/11/21
Chowdhury N, Khalid A, Turin TC | Z Gesundh Wiss
Aim: To quickly synthesize existing literature about misinformation during recent abrupt large-scale infectious disease outbreaks.
INFECTION CONTROL
5/10/21
Kim H, Hwang H, Hong H, et al. | Sci Rep
Aim: To review the differences in risk factors for critical outcomes of patients with COVID-19 according to the continent on which the studies were performed.
CLINICAL CHARACTERISTICS
5/10/21
Taha M, Samavati L | RMD Open
Aim: To examine the prevalence of aPL and its clinical impact in patients with COVID-19.
CANDIDATE THERAPEUTICS
5/10/21
Ghodsi A, Bijari M, Alamdaran SA, et al. | World J Pediatr
Aim: To evaluate the chest computed tomography (CT) findings in infants with confirmed COVID-19 infection
CLINICAL CHARACTERISTICS
5/10/21
Dong Y, Shamsuddin A, Campbell H, et al. | J Glob Health
Aim: To describe existing SARS-CoV-2 therapeutic approaches and present the results of their current COVID-19 clinical trials.
CANDIDATE THERAPEUTICS
5/10/21
Menon T, Gandhi SAQ, Tariq W, et al. | Cureus
Aim: To provide an association between CKD and the clinical prognosis of COVID-19.
CLINICAL CHARACTERISTICS
5/10/21
Saadatjoo S, Miri M, Hassanipour S, et al. | Public Health
Aim: To investigate and synthesize the current evidence on knowledge, attitudes, and practices (KAPs) of the general population regarding COVID-19.
INFECTION CONTROL
5/10/21
Ippolito M, Catalisano G, Marino C, et al. | Resuscitation
Aim: To estimate the mortality rate, the rate of return of spontaneous circulation (ROSC) and survival with favorable neurological outcome in patients with COVID-19 after in-hospital cardiac arrest (IHCA) and attempted cardiopulmonary resuscitation (CPR).
CLINICAL CHARACTERISTICS
5/10/21
Musuuza JS, Watson L, Parmasad V, et al. | PLoS One
Aim: To examine the occurrence of co-infections and superinfections and their outcomes among patients with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
5/10/21
Turner S, Botero-Tovar N, Herrera MA, et al. | Implement Sci
Aim: To depict the experiences and perceptions of organisations and actors at multiple levels of health systems internationally in responding to COVID-19.
UPDATED
INFECTION CONTROL
5/10/21
Klassen SA, Senefeld JW, Johnson PW | Mayo Clin Proc
Aim: To determine the effect of COVID-19 convalescent plasma on mortality.
CANDIDATE THERAPEUTICS
5/10/21
Lazaridis D, Leung S, Kohler L, et al. | J Pharm Pract
Aim: To review the evidence on the impact of anticoagulation on COVID-19 patient outcomes.
CANDIDATE THERAPEUTICS
5/7/21
Watt JA, Lane NE, Veroniki AA, et al. | J Am Geriatr Soc
Aim: To compare the diagnostic accuracy of virtual to in-person cognitive assessments and tests and barriers to virtual cognitive assessment implementation.
DIAGNOSTICS
5/7/21
Gulsen A, Konig I, Jappe U, et al. | Respirology
Aim: To examine in detail whether the underlying chronic obstructive pulmonary diseases (COPD), asthma and chronic respiratory diseases (CRDs) were associated with an increased risk of more severe COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
5/7/21
Mutiawati E, Syahrul S, Fahriani M, et al. | F1000Res
Aim: To determine the prevalence of headache in coronavirus disease 2019 (COVID-19) and to assess its association as a predictor for COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Aladawi M, Elfil M, Abu-Esheh B, et al. | Can J Neurol Sci
Aim: To review the evidence on the association between Guillain Barre Syndrome and COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Dembrovszky F, Váncsa S, Farkas N, et al. | Viruses
Aim: To evaluate which prognostic factors may impact repeated SARS-CoV-2 positivity (RSP) and their association with immunoglobulin detectability among recovered patients. 
UPDATED
CLINICAL CHARACTERISTICS
5/7/21
Rosenberger KJ, Xu C, Lin L | J Eval Clin Pract
Aim: To methodologically assess the current systematic reviews and meta-analyses on COVID-19.
5/7/21
Aldien AS, Ganesan GS, Wahbeh F, et al. | Cardiovasc Revasc Med
Aim: To investigate the possible role of hyperinflammation in inducing cardiac injury as one of the severe complications of COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Lu Y, Zhao J, Ye M, et al. | Neurol Sci
Aim: To determine the risk of acute ischemic stroke in patients with severe and non-severe coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
5/7/21
Cosco TD, Best J, Davis D, et al. | Age Aging
Aim: To quantify the association between frailty and COVID-19 in relation to mortality in hospitalised patients.
UPDATED
CLINICAL CHARACTERISTICS
5/6/21
Chee ML, Ong MEH, Siddiqui FJ, et al. | Int J Environ Res Public Health
Aim: To systematically review and critically appraise the current evidence on AI applications for COVID-19 in intensive care and emergency settings.
DIAGNOSTICS
5/6/21
Ayubi E, Bashirian S, Khazaei S | J Gastrointest Cancer
Aim: To systematically review and meta-analysis of studies that evaluated the level of depression and anxiety in cancer patients during the COVID-19 pandemic.
MENTAL HEALTH
5/6/21
Angelico R, Blasi F, Manzia TM, et al. | Medicina
Aim: To investigate the current management of IS therapy in KT recipients with COVID-19. 
CLINICAL CHARACTERISTICS
5/6/21
Suklan J, Cheaveau J, Hill S, et al. | Viruses
Aim: To statistically summarise routine laboratory biomarker measurements in COVID-19-positive and -negative patients to inform future work.
DIAGNOSTICS
5/5/21
Shah R, Priyadarshini G, Parsana M | Indian J Otolaryngol Head Neck Surg
Aim: To give a brief review of available data on COVID-19 related to the timing, personal protections, operative steps modifications, and subsequent post tracheostomy care during this pandemic.
CANDIDATE THERAPEUTICS
5/5/21
Szarpak L, Borkowska M, Peacock FW, et al. | Cardiol J
Aim: To review interventional outcome studies in patients with in-hospital cardiac arrest before and during the coronavirus disease 2019 (COVID-19) pandemic period.
CLINICAL CHARACTERISTICS
5/5/21
Li X, Zhong X, Wang Y, et al. | PLoS One
Aim: To systematically identify the possible risk factors responsible for severe cases.
CLINICAL CHARACTERISTICS
5/5/21
Yousefi M, Oskoei V, Jafari AJ, et al. | Environ Sci Pollut Res Int
Aim: To determine the effects of COVID-19 on the quantity of waste and municipal solid waste management.
INFECTION CONTROL
5/5/21
Chetty T, Ramokolo V, Rees K, et al. | S Afr Med J
Aim: To assess the effectiveness of cloth and medical masks for preventing SARS-CoV-2 transmission in community settings.
INFECTION CONTROL
5/5/21
Rehman MA, Farooq H, Ali MM, et al. | SN Compr Clin Med
Aim: To identify cases of subacute thyroiditis associated with COVID-19 and evaluated patient-level demographics, major clinical features, laboratory findings and outcomes.
CLINICAL CHARACTERISTICS
5/4/21
Du P, Li D, Wang A, et al. | Can J Infect Dis Med Microbiol
Aim: To screen the risk factors for severe illness and death and provide help for early clinical treatment of the new coronavirus (COVID-19).
CLINICAL CHARACTERISTICS
5/4/21
Bilal U, Gullón P, Padilla-Bernáldez J | Gac Sanit
Aim: To review the scientific epidemiologic evidence on the role of hospitality venues in the incidence or mortality from COVID-19.
INFECTION CONTROL
5/4/21
Dos Santos ACM, Dos Santos BRC, Dos Santos BB, et al. | Infect Genet Evol
Aim: to review the effect of single nucleotide polymorphisms in the development of severe acute respiratory syndrome (SARS).
UPDATED
CLINICAL CHARACTERISTICS
5/4/21
Hariyanto TI, Rosalind J, Christian K, et al. | South Afr J HIV Med
Aim: To explore the impact of HIV and SARS-CoV-2 co-infection on mortality.
CLINICAL CHARACTERISTICS
5/4/21
Nepal G, Shrestha GS, Rehrig JH, et al. | J Nepal Health Res Counc
Aim: To review the evidence on neurological involvement in COVID-19 associated MIS-C.
CLINICAL CHARACTERISTICS
5/4/21
Liang M, Luo N, Chen M, et al. | Infect Dis Ther
Aim: To investigate the prevalence and mortality in PLWHA co-infected with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/3/21
Peixoto AO, Costa RM, Uzun R, et al. | Pulmonology
Aim: To review the evidence on the use of lung ultrasound in COVID-19.
5/3/21
Pb S, Mittal S, Madan K, et al. | Monaldi Arch Chest Dis
Aim:  To evaluate the available evidence and performed meta-analysis of the effect of awake PP in non-intubated patients on improvement in oxygenation and reducing the need for intubation.
5/3/21
Siegel A, Zuo Y, Moghaddamcharkari N, et al. | Curr Opin Psychiatry
Aim: To synthesize the extant literature reporting on barriers of telemental health (TMH) during the COVID-19 pandemic and how facilities have worked to overcome these barriers, to inform best practices for TMH delivery.
5/3/21
Neira C, Godinho R, Rincon F, et al. | Nutrients
Aim: To evaluate the current evidence about the impact that preventive measures of physical contact restriction causes in healthy nutrition.
UPDATED
5/3/21
Gianfredi V, Mauer NS, Gentile L, et al. | Int J Environ Res Public Health
Aim: To evaluate the available scientific evidence on the risks of recreational skiing for the evolution of the COVID-19 pandemic.
5/3/21
Corrao S, Mallaci Bocchio R, Lo Monaco M, et al. | Nutrients
Aim: To analyze the current knowledge from systematic reviews of the relationship between nutraceutical supports and the reduction in inflammatory response to formulate clinical recommendations and highlight directions for future research during the COVID-19 pandemic. 
5/3/21
Nobari H, Fashi M, Eskandari A, et al. | Int J Environ Res Public Health
Aim: To assess and provide an up-to-date analysis of the impact of coronavirus disease 2019 (COVID-19) pandemic on the health-related quality of life (HRQoL) of children and adolescents.
5/3/21
Tleyjeh IM, Kashour Z, Riaz M, et al. | Clin Microbiol Infect
Aim: To perform a living systematic review of the literature about the efficacy and toxicity of the IL-6 receptor antagonist, tocilizumab, in COVID-19 patients.
UPDATED
CANDIDATE THERAPEUTICS
5/3/21
Regmi K, Lwin CM | Int J Environ Res Public Health
Aim: To review the factors associated with the implementation of NPIs (social distancing, social isolation and quarantine) for reducing COVID-19.
5/3/21
La Verde M, Riemma G, Torella M, et al. | Int J Gynaecol Obstet
Aim: To evaluate the characteristics of pregnant women deceased due to COVID-19.
UPDATED
5/3/21